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ABSTRACT 
 
Grapefruit-Drug Interaction: Isolation, Synthesis and Biological Activities of 
Furocoumarins and Their Variation due to Pre- and Post–Harvest Factors. (August 2007) 
Basavaraj Girennavar, B. Sc., University of Agricultural Sciences Dharawad, India; 
M. Sc., Haryana Agricultural University Hisar, India 
Chair of the Advisory Committee: Dr. Bhimanagouda S. Patil 
 
The health maintaining properties of citrus consumption are attributed to the wide 
assortment of bioactive compounds. Consumption of grapefruit along with certain 
medications, however, is posing a risk of drug toxicity and side reactions. The first study 
involved isolation of bioactive furocoumarins with a combination of chromatographic 
techniques and synthesis. Five furocoumarins namely, dihydroxybergamottin, paradisin 
A, bergamottin, bergaptol and geranylcoumarin were isolated from grapefruit and series 
of furocoumarin monomers and paradisin A were synthesized. The second study involved 
influence of pre- and post-harvest factors on the levels of furocoumarins in grapefruit 
juice. Considerable differences were observed in the levels of these compounds in 
different grapefruit cultivars. Ray Red showed the lowest levels of all three 
furocoumarins and Duncan contains the highest amount of DHB and bergamottin, where 
as the highest levels of paradisin A was observed in Star Ruby. The highest levels of 
DHB and bergamottin were found in Flame cultivar grown in California. The changes in 
the levels of these furocoumarins during the season in Rio Red and Marsh White 
grapefruit cultivars were evaluated.  
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The third study investigated biological activities of grapefruit juices and 
furocoumarins. Grapefruit and Pummelo juices were found to be potent inhibitors of 
cytochrome CYP3A4 and CYP2C9 isoenzymes at 5% concentration while CYP2D6 was 
less affected.  Among the five furocoumarins tested, the inhibitory potency was in the 
order of paradisin A>dihydroxybergamottin>bergamottin>bergaptol>geranylcoumarin at 
0.1 µM to 0.1 mM concentrations. A fourth study investigated the effect of 
furocoumarins on bacterial auto-inducer signaling, and found that furocoumarins are 
potent inhibitors of AI-1 and AI-2 activities at 0.01% concentration. In a fifth study, 
involving synthesized furocoumarin monomers and dimer on anti-proliferative activities 
on normal and cancer cell lines, furocoumarins found to be non-toxic to normal cells. 
However, bergamottin showed a significant anti-proliferative activity in HT-29 and 
MCF-7 cell lines. 
This dissertation indicates that furocoumarins are bioactive compounds from 
grapefruit juice with potent inhibitory property of major drug metabolizing cytochrome 
P450 isoenzymes. Furocoumarins show a considerable variation between varieties, 
location and season. These results corroborate the involvement of furocoumarins in 
grapefruit drug interaction. 
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CHAPTER I 
INTRODUCTION 
 
Background 
Citrus is an important crop of subtropical areas, and red grapefruit (Citrus 
paradisi Macf.) is both a popular and state fruit of Texas (1, 2). The United States is the 
world’s largest producer and exporter of grapefruit; produced mainly in Florida, Texas, 
California, and Arizona states (3). Purchased by 21% of United States households, 
grapefruit juice carries the American Heart Association’s healthy “heart check” food 
mark (4, 5). Grapefruit contains a cultivar of bioactive health maintaining compounds 
such as ascorbic acid, flavonoids, limonoids, folic acid, carotenoids, pectin, potassium, 
furocoumarins and related compounds. These compounds may serve as health 
maintaining and act as chemo-preventive bioactive functional components of citrus (6). 
Citrus flavonoids, such as hesperidin and naringin, possess antioxidant activity (7) and 
naringin suppress high multiplicity aberrant crypt foci formation and cell proliferation in 
rat colon (8). Carotenoids, such as lutein, showed antioxidant activity with its potential 
role in protection against prostate cancer and age-related macular degeneration (9). 
Grapefruit sales and crop value have declined since 1990’s, due in part to 
consumer concerns about possible drug interactions and drug toxicity when consumed 
with common prescription medications (10, 11). This is particularly critical in that juice 
_________________ 
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and medications are commonly consumed together at breakfast. Survey results show that 
multiple drug use is common in the United States. More than 50% of individuals in a 
given week would be taking at least one prescription drug and 7% would be taking at 
least five prescription drugs (12). In AIDS and cancer patients, the use of multiple 
prescription drugs and dietary supplements is prevalent (13). This presents a challenge in 
managing patient’s health care in the context of common food-drug interaction. 
Grapefruit juice has been reported to increase bioavailability of many drugs 
metabolized by cytochrome P4503A4 (CYP3A4) enzyme. The drugs affected include a 
number of dihydropyridine calcium channel antagonists (14-16), triazolam, terfanidin, 
diltiazem, simvastatin, lovastatin, cyclosporine, sildenafil (17-21). The possible 
mechanism of grapefruit juice induced-drug interactions is through inhibition of the drug-
metabolizing enzyme cytochrome P4503A4 (22-23), intestinal membrane efflux 
transporter P-glycoprotein (24-28) and the organic anion-transporting polypeptides (29-
32). These mechanisms may alter drug metabolism, transportation and cellular uptake of 
xenobiotic compounds (33). This comprehensive effect of altered drug metabolism 
results in a significant reduction of the pre-systemic metabolism of drugs leading to a 1.5- 
to 15- fold increase in blood plasma concentration (11). 
 
Citrus Bioactive Compounds 
Citrus is a subtropical, evergreen genus originating from Southeast Asia and 
belongs to the Rutaceae family. The plants are large shrubs or small trees, reaching 5-15 
meters in height with spiny shoots and alternately-arranged leaves. Citrus fruits are 
notable for their fragrance, mainly due to terpenes and essential oils present in the rind. 
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Citrus fruits are consumed both as fresh and processed products. The fresh crop value of 
citrus in Florida and Texas alone was $493.2, million $50.0 million, respectively and the 
value of processed citrus products was more than $3.7 billion between 1999 and 2000 
(34). The most important citrus crops in the United States are oranges and grapefruits, 
and demand for grapefruit is declining as consumer concern about possible interaction of 
grapefruit juice with certain medication is increasing.  
Consumption of fruits and vegetables, especially citrus, has long been known to 
prevent many human diseases, from scurvy to several types of cancers (35). The health-
maintaining properties of citrus fruits are attributed to the presence of several bioactive 
compounds (35).  Grapefruit juice has been shown to suppress carcinogen induced DNA 
damage (36). Initially, it was assumed that vitamin C was the active agent with all the 
potential health-benefits. However, recent investigations showed several bioactive 
compounds with health maintaining properties in vivo and in vitro (35-37). 
 
Furocoumarins and Their Biosynthesis 
 Furocoumarins are minor constituent compounds present in species belonging to 
the Umbelliferae, Rutaceae, Moraceae, Rosaceae and Leguminosae families. 
Furocoumarins are also referred to as psoralens (38). These naturally-occurring 
furocoumarins have been used clinically, coupled with ultraviolet light, to treat 
dermatological disorders for more than 2000 years (38). Furocoumarins are known to 
posses photo-sensitizing properties and have been used extensively in photo-
chemotherapy (38). In vitro studies showed to inhibit the activity of several mammalian 
cytochrome P450 enzymes such as CYP3A4, CYP1A, CYP2D6 and CYP2B1 (39). Other 
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studies reported the involvement of furocoumarins as the main components of grapefruit 
juice, in grapefruit-drug interaction by inhibiting the CYP3A4 enzymes metabolic 
activity (40, 41). Grapefruit juice contains several furocoumarins and their derivatives, 
which are believed to be responsible for drug interactions. Until recently, six 
furocoumarins had been found in grapefruit juice with differential inhibitory effects on 
CYP P450 enzymes (42). Bergamottin and 6’, 7’–dihydroxybergamottin are the major 
furocoumarins, whereas paradisin A, paradisin B and paradisin C are strong inhibitors of 
microsomal CYP3A4 (42).  
 Furocoumarins are phytoalexins produced by several plant species to protect against 
biotic and abiotic stresses (43). Furocoumarins biosynthesis can be induced by 
herbivores, pathogens and environmental stresses leading to their accumulation of the 
furocoumarins in leaf tissue (44). Furocoumarins in wild parsley and celery are thought to 
cause occupational “phyto-photo-dermatitis” in farm workers, when they are exposed to 
sunlight. Plants during the ecological war with herbivores vary their production of 
furocoumarins to maintain their defending ability. Cell suspension cultures have been 
used to study the induction of furocoumarins production in response to fungal elicitors 
and most of the elicited furocoumarins accumulated in the culture fluid (45). Induction 
and accumulation of umbelliferone 7-O-prenyltransferease and a 6-C-prenyltransferase 
activity were reported in elicitor-treated Ammi majus cell suspension cultures (45).  
 
Mechanism of Grapefruit-Drug Interaction 
Most lipophilic drugs are either metabolized by CYP3A4 or pumped back into the 
gut lumen by the P-glycoprotein transporter. Thus, CYP3A4 and P-glycoprotein act in 
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tandem as a barrier to the oral delivery of many drugs (46). It seems that many bioactive 
compounds from grapefruit juice, such as furocoumarins and flavonoids, interfere with 
CYP3A4 activity. Interestingly, grapefruit juice has no effect on the bioavailability of 
drugs when they are administered intravenously (47), suggesting the involvement of 
intestinal CYP3A4 inhibition, not the hepatic CYP3A4 inhibition, as the major cause for 
increased oral bioavailability (48, 49). Bergamottin, a major furocoumarin in grapefruit 
juice, reversibly inhibits the activities of CYP1A2, CYP2A6, CYP2C9, CYP2C19, 
CYP2D6, CYP2E1 and CYP3A4 in human liver microsomes (50). Bergamottin also 
inactivates CYP3A4 after metabolic activation in a time- and concentration-dependent 
manner (50). Bergamottin-induced inactivation led to the loss of up to 50% of CYP3A4 
apoprotein, perhaps via apoprotein modification at the active site of the enzyme (50). 
Metabolites of bergamottin may undergo oxidation to form a reactive furanoepoxide that 
covalently binds to CYP3A4 (51). Grapefruit juice seems to interact with P-glycoprotein 
because P-glycoprotein and CYP3A4 have overlapping substrate specificities. 
 
Factors Influencing Bioavailability of Drugs 
The oral intake of a drug contemplates that the body must first absorb the active 
ingredient before it can reach the target organ. The efficacy of drug uptake depends on 
the chemical characteristics of the active substance such as its solubility and membrane 
permeability. However, absorption of the drug is also determined by the organism’s 
ability to absorb pharmaceuticals through a specific transporter system, and later being 
able to excrete them. Since many pharmacologically active substances are poorly suited 
for oral intake, a decisive criterion for the efficacy of a medicine is its bioavailability. 
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Therefore, bioavailability is a measure the rate of the absorption of a drug as well as the 
extent to which this drug is absorbed (52). 
Multiple factors influence the absorption of a single drug. The external conditions 
that influence the bioavailability of drugs are related to the total patient–environment and 
modifiers at the time of the drug administration (53). For example, the quality, quantity, 
temperature and food consumed along with drug, as well as the time taken relative to the 
intake of the drug, can have an effect on the degree of absorption. Other factors such as 
consuming liquids and social drinks coffee, tea and alcoholic substances influence the 
absorption of a drug (53). It is also possible that the somatic and psychological 
characteristics of the patient have an effect on the extent of bioavailability of a drug. 
Specific anthropometric factors such as race, sex, age, height, and weight may also 
influence the extent of bioavailability of the drug. Furthermore, daily habits and living 
conditions may have an influence on drug bioavailability. The regular use of self-
medicated drugs such as laxatives, antacids, vitamins and sedatives may interfere with 
absorption and metabolism of drugs (53). In addition, the deliberate control and normal 
frequency of urination and defecation may influence the rate of elimination of a drug, 
thus changing the general pattern of the concentration-time curve expected for a 
particular drug (53). 
 
Food-Drug Interactions 
The presence of food, solid or liquid, within the gastro-intestinal tract can 
markedly modify the oral availability of drugs via changes in the pre-systemic 
metabolism and systemic drug clearance (54). These alterations may occur from a dietary 
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material effect on the saturation solubility of a drug in the gastro-intestinal tract. These 
include the crystalline form, lipophilicity and the ability of the drug to be solubilized by 
the native surfactants and co-ingested food stuffs, its aqueous solubility, pK and GI tract 
pH profile (55).  Direct interactions between drugs and dietary substance can also 
decrease or increase dramatically the absorption of susceptible xenobiotics. These 
interactions include the absorption of the drug to insoluble dietary components, chelation 
with metal ions and partitioning or solubilization in dietary fat, which is major constituent 
that can influence drug absorption (54). 
 
Cytochrome P450 Enzymes 
Cytochrome P450 is a large multi gene family of heme-containing proteins found 
in the intestinal wall and liver, where they play an important role in the oxidative 
biotransformation of numerous drugs, endogenous substances and xenobiotics (56, 57). 
Several isoforms have been characterized based on their structure, substrate specificity 
and response to various types of inducers (58). Individual isoenzymes are thought to be 
responsible for the metabolism of specific substrates.  The CYP3A subfamily is the most 
abundant enzyme; 70% of the enzyme is localized in the liver and 30% in the enterocytes. 
Furthermore, CYP3A4, CYP2C9 and CYP2D6 are major drug metabolizing enzymes 
(59).  Certain cytochrome P450 isoenzymes such as, CYP3A4, CYP1A2, CYPB1 and 
CYP9 have a specific role in the onset of several types of cancers (60-62).   
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P -glycoprotein 
P-glycoprotein is an ATP-binding cassette (ABC) family membrane transporter, 
located in the intestinal gut wall. The function of the P-glycoprotein is to carry lipophilic 
molecules from intestinal epithelial cells back into the intestinal lumen (63). After uptake 
of a drug by enterocytes, many lipophilic drugs are either metabolized by CYP3A4 or 
pumped back into the lumen by P-glycoprotein (64).  Therefore, CYP3A4 and P-
glycoprotein act as tandem barriers to the oral delivery of many drugs (65). Over-
expression of certain ABC transporters occurs in cancer cell lines and tumors that are 
multi-drug resistant. Genetic variation in these genes contributes to a wide cultivar of 
human disorders such as cystic fibrosis, neurological disease, retinal degeneration, 
cholesterol and bile transport defects, anemia, and drug response phenotypes (66). 
Inhibition of these transporter proteins in selected patient populations would offer a 
unique strategy to cure the above disorders and diseases.  
 
Antimicrobial Activity of Bioactive Compounds 
One of the properties of citrus flavonoids, which is related to their physiological 
action in plants, is their antifungal and antiviral activity. Grapefruit peel extracts showed 
varying degrees of antibacterial activity. Among the extracts, ethanol soluble fraction was 
most effective against Gram-positive bacteria (67). Methoxyflavones, flavanones and 
coumarins are the main chemical constituents of grapefruit peel, and some coumarins 
have been reported to have anti-platelet aggregating and anti-mutagenic activity (67).  
The antibacterial agents from grapefruit can be used as a bio-preservative in the food 
industries. It has been shown that grapefruit extract possess antibacterial and antifungal 
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activity in vitro and inhibits the proliferation of Candida, a yeast that can impinge upon 
probiotic bacteria and affect the gastrointestinal health. Heggers et al., reported the 
mechanism of action and in vitro toxicity of grapefruit extracts (68). Synthetic and 
natural furanones are potential anti-quorum sensing agents in bacteria and have been 
studied for their antibacterial properties in food and medical microbiology (69). 
Unfortunately, halogenated furanone compounds are unsuitable for human use due to 
unstable and toxicity. Furanones and furocoumarins share similarity in having a furan 
moiety in their structure. There is a need for identification and evaluation of naturally 
occurring anti-quorum sensing compounds from plants which are safe alternatives to the 
halogenated furanones and fungus derived mycotoxins. 
 
Effects of Pre-Harvest Factors on Bioactive Compounds 
The bioactive compound profile of citrus fruits varies with cultivar, 
environmental conditions and fruit development and maturity. Duncan seedy and marsh 
seedless grapefruit showed variation in naringenin and limonin content (70, 71). 
Grapefruit trees exposed to freezing conditions showed more naringin and less limonin 
(71). Other environmental stress parameters such as temperature and humidity affect the 
level of naringin (72, 73). Grapefruit showed quantitative changes in the phytochemical 
levels of juices during developmental stages. The highest concentration of naringin (74, 
75), limonin (76) and nomilin (77) were observed at early developmental stage and 
progressively declined as the fruit matured.  
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Effects of Post-Harvest Factors on Bioactive Compounds 
Several post-harvest factors such as temperature, relative humidity, atmosphere 
conditions and processing affect the quality of fruits. It is well known that in certain 
fruits, quality declines from the time of the harvest, particularly if the produce is not 
cooled effectively. The contents of bioactive furocoumarins in different lots of 
commercial grapefruit juices samples showed considerable variation (10). A study 
conducted in Japan on commercial grapefruit juices showed four fold variation of 
bergamottin, 43- fold variation of dihydroxybergamottin (DHB) and 65- fold variations 
of dimers (78, 79). Manually-squeezed grapefruit juice increased the bioavailability of 
terfanadine more than two-fold compared to the industrially processed juice (17). It is 
possible that the hand-squeezed juice contain more drug-interaction causing bioactive 
components compared to commercially-processed juice. Commercially, grapefruit juice 
is manufactured in a multi-step process, which includes washing, puncturing of peel to 
obtain essential oils and squeezing of the whole fruit to juice. The juice is heated to175 ºF 
during pasteurization process and then essential oils, important constituents of grapefruit 
peel, are added as a flavor enhancer (86). 
Based on the research information on grapefruit-drug interaction, we 
hypothesized that furocoumarins are the bioactive agents responsible for grapefruit juice 
induced-drug interaction by inhibiting cytochrome P450 enzymes and P-glycoprotein 
activities and variability in the levels of the furocoumarins levels may be the prime 
reason for variation in the drug bioavailability. To test this hypothesis, we proposed the 
following objectives for the dissertation: 
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• Isolation and synthesis of furocoumarin monomers and dimer.  
• To evaluate the effect of pre-harvest factors on the levels of furocoumarins in 
grapefruit. 
• To evaluate the effect of post-harvest factors on the levels of furocoumarins in 
grapefruit and grapefruit juice. 
• To evaluate the effect of grapefruit juice and furocoumarins on CYP P450 
3A4, 2C9 and 2D6 isozymes and P-glycoprotein. 
• To evaluate the effect of grapefruit juice and its furocoumarins on bacterial 
quorum sensing and biofilm formation. 
• To evaluate the Anti-proliferative properties of furocoumarins on normal and 
cancer cell lines.   
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CHAPTER II 
ISOLATION AND SYNTHESIS OF FUROCOUMARIN MONOMERS AND 
DIMER   
Synopsis 
Bioactive furocoumarins know to have drug-interaction properties were isolated 
with a combination of chromatographic techniques. An efficient and improved technique 
was developed for the isolation and purification of furocoumarins using an open and 
reverse phase column chromatography. Grapefruit juice was extracted with ethyl acetate 
and the dried extract was loaded on to a silica gel column. The column was eluted with a 
combination of solvents, ranging from non-polar (hexane) to polar (methanol) solvents. 
Furthermore, column fractions were subjected to preparative HPLC to obtain four 
compounds 6’ 7’- dihydroxybergamottin, bergamottin, paradisin-A and bergaptol. 
Grapefruit peel oil was loaded on to preparative HPLC column and eluted with aqueous 
methanol. The fraction containing geranylcoumarin was rotary evaporated and freeze 
dried. The purity of these compounds was analyzed by HPLC and structures were 
determined by LC-MS and NMR studies. Series of monomers and a dimer were 
synthesized starting from bergapten.  
 
Introduction 
Phytochemicals are non-nutritive plant compounds that have disease protective or 
preventive properties. Plants produce these chemicals to protect themselves against a 
cultivar of stresses. Phytochemicals can range from medicinally useful agents to deadly 
poisons. Today a number of phytochemicals isolated from plants are used as drugs in the 
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pharmaceutical industry. Natural compounds from plants serve as a vital source for new 
drugs and model structures for synthetic formulations (80). Citrus flavonoids, such as 
naringenin, apigenin, hesperetin and quercetin are potent inhibitors of cytochrome 
enzymes. Other compounds such as limonin glucoside and nomilin glucoside showed 
CYP 19 enzyme inhibition. Naringin and its aglycone, naringenin, were thought to be the 
grapefruit agents responsible for drug interactions. However, when naringin was co-
administered with felodipine in vivo, no changes in bioavailability of felodipine was 
observed, thus indicating the involvement of non-flavonoid component of grapefruit juice 
in drug interaction (40).  
Furocoumarins play a significant role in the grapefruit juice drug interactions by 
inhibiting CYP3A4 enzyme and transporter proteins (24, 25). Furocoumarins are 
polyphenolic compounds, synthesized from L-phenylalanine and may occur in linear 
form with a furan ring attached to the 6, 7, position of the benzo-2 pyrene nucleus. These 
compounds are toxic in nature, acting as pro-oxidants by covalently binding to DNA and 
proteins in the presence of ultraviolet light (81). Bergamottin is the major furocoumarin 
in fresh grapefruit, present at similar levels in the juice and segment membranes but to a 
lesser extent in the peel extracts (82, 83). Unlike flavonoids and limonoids, 
furocoumarins are not concentrated in the peel or peel oil but mainly distributed in the 
juice (83). Since bioactive furocoumarins in grapefruit juice have been shown to interact 
with cytochrome enzymes, it is imperative to isolate and characterize them from 
grapefruit juice. Thus the objective of this study was to isolate furocoumarins from 
grapefruit and also to explore the possibility of synthesizing them for evaluating 
biological activity. 
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Materials and Methods 
Chemicals. All the solvents and chemicals used were GR and HPLC grade and 
were obtained from EMD chemicals Inc., Gibbstown, NJ. Silica gel of 200-400 mesh size 
60 A for column chromatography was purchased from Aldrich Chemical Company Inc. 
(Milwaukee, WI).  
Grapefruit Juice and Grapefruit Peel Oil. Concentrated grapefruit juice and 
grapefruit peel oil was donated by the Texas Citrus Exchange (Mission, TX). The 
concentrated grapefruit juice was stored at 5 °C and 95% relative humidity until further 
processing.  
Extraction. Concentrated grapefruit juice (20L) was diluted by stirring with 
distilled water to attain a brix reading of 30%. The diluted juice (50 L) was extracted with 
ethyl acetate in 1:1 ratio three times, consecutively. The organic layer was separated and 
dried to obtain a crude extract. 
Purification of Furocoumarins. Dried ethyl acetate extract (23 g) was 
impregnated with 23 g of silica gel and loaded on to a silica gel (500 g) column. The 
column was eluted with hexane:ethyl acetate with increasing polarity as follows 95:5, 
90:10, 85:15, 80:20, 60:40, 40:60 0:100. All the fractions were analyzed by TLC and 
HPLC. Fractions containing similar peaks were pooled and concentrated under vacuum. 
Fractions eluted with hexane: ethyl acetate (80:20) showed compounds of interest and 
these fractions were concentrated under vacuum.  
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Preparative HPLC of Column Fractions.  The preparative HPLC run was 
performed using a Waters prep HPLC system (Waters Corporation, Milford, MA). The 
mobile phase used was as follows, Solvent A (methanol) and solvent B (water), 0 min, 
40% A; 45 min, 45% A; 90 min, 60% A; 120 min, 90% A; 130 min, 95% A. The flow 
rate was set at 25 mL/min and detection was carried out at 240 nm. The vacuum 
concentrated fraction was reconstituted with methanol and injected into the preparative 
HPLC column.  Different fractions were collected according to the peak retention times 
and fractions were further analyzed with TLC and HPLC. Fractions having similar 
retention times were pooled, evaporated under vacuum and freeze-dried. The yields of 
compound 1, 2, 3 and 4 were 340, 19, 310, and 451 mg, respectively. 
Preparative HPLC for Grapefruit Peel Oil. The preperative HPLC run was 
performed with the above mentioned system and method. Five mL of grapefruit peel oil 
was filtered and injected on to the column and eluted with aqueous methanol. Different 
fractions were collected according to the peak retention times and fractions were 
analyzed with TLC and HPLC. Fractions having similar retention times were pooled, 
evaporated under vacuum and freeze-dried. The yield of compound 5 was 280 mg. 
TLC Analysis. Purified compounds were dissolved in methanol, spotted on TLC 
plates and developed using hexane: ethyl acetate (4:1) as mobile phase. The compounds 
were visualized as black spots when sprayed with 10% sulfuric acid in methanol followed 
by heating at 110 °C for 10 min. 
HPLC Analysis. The HPLC system consisted of a Thermo Electron Corporation 
P-400 quaternary HPLC pump (Thermo Electron Corporation San Jose, CA), Membrane 
degasser LDC analytical and Spectra system AS3000 auto sampler. Peaks were analyzed 
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with Thermo separation products PDA detector.  Chromatographic separations were 
accomplished on Chemcosorb-5-ODS column (150 × 6.0 mm, 5 µm particle size) 
(ChemcoPak, Osaka, Japan). Elution was carried out at room temperature under gradient 
conditions with a mobile phase starting from (A) methanol and (B) water, over a period 
of 65 min. Starting with 60% A; 20 min, 80% A; 25 min, 80% A; 45 min, 85% A; 50 
min, 90% A; 55 min, 95% A; 60 min, 100% A; 65 min, 100% A. The flow rate was set at 
1.1 mL / min and elution was monitored with UV detection at 240.  
Identification.  1H and 13C NMR spectra were recorded at 300 and 75 MHz 
respectively, on a JEOL AMX 300 FT instrument (JEOL-USA, Inc., Peabody, MA).  
TMS was used as internal standard. 13C NMR assignments were given on the basis of 
FLOCK, DEFT spectra.  
Synthesis of Furocoumarins  
Bergaptol: 4-Hydroxy-7H-furo-[3,2-g]chromen-7-one [7]. To a solution of 
bergapten [1] (1.8 g, 8 mmol) in dichloromethane (70 mL), BBr3 (70 mL, 70 mmol, 1 M 
in DCM) was added drop wise and the mixture was stirred under argon at room 
temperature. After 4 hours the mixture was poured slowly into a solution of saturated 
sodium bicarbonate (400 mL) resulting in the precipitation of a yellowish solid. After 30 
minutes of stirring, the product was recovered by filtration, washed with cold water and 
ether and dried under a high vacuum, yielding the compound [7] as an off-white solid 
(1.621 g, 7.9 mmol, 99%). 1H NMR (d6 -acetone, 300 MHz): d 8.28 (d, 1H, J = 9.8 Hz), 
7.8 (d, 1H, J = 2.3 Hz), 7.17 (d, 1H, J = 2.3 Hz), 7.06 (s, 1H), 6.24 (d, 1H, J = 9.8 Hz); 
m/z (EI) 202 (100%, M+). 
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Bergamottin. 4-(3, 7-Dimethylocta-2,6-dienyloxy)-furo[3,2-g]chromen-7-one 
[8]. Geranyl bromide (2.1 g, 9.6 mmol) was added drop wise to a stirred mixture of 
bergaptol [7] (1.571 g, 8 mmol) and potassium carbonate (1.656 g, 12 mmol) in acetone 
(100 mL) at RT, then the mixture was heated under reflux for 2 hour. Aqueous citric acid 
(5% w/v) was added to neutralize the potassium carbonate and the solution was extracted 
with DCM (2 × 100 mL). The combined organic layers were washed with water and brine 
and were dried (Na2SO4). Removal of the solvent under reduced pressure furnished a 
pale yellow oil, which was purified by column chromatography eluting with ethyl 
acetate–hexane (1 : 4). Removal of the solvent under reduced pressure afforded a white 
crystals of the compound [8] (2.4943 g, 7.9 mmol, 95%). 1H NMR (CDCl3, 300 MHz): d 
8.18 (d, 1H, J = 9.8 Hz), 7.61 (d, 1H, J = 2.1 Hz), 7.16 (s, 1H), 6.97 (d, 1H, J = 2.1 Hz), 
6.29 (d, 1H, J = 9.8 Hz), 5.54 (t, 1H, J = 6.5 Hz), 5.07 (bs, 1H), 4.96 (d, 2H, J = 6.5 Hz), 
2.09 (s, 4H), 1.69 (s, 6H), 1.60 (s, 3H); m/z (EI) 338 (17%, M+), 202 (100%). 
Epoxybergamottin. 4-[5-(3,3-Dimethyloxiranyl)-3-methylpent-2-enyloxy]-
furo[3,2-g]chromen-7-one (epoxybergamottin) [9]. 3-Chloroperoxybenzoic acid (776 mg, 
3.15 mmol) was added to a stirred solution of bergamottin [8] (710 mg, 2.1 mmol) in 
DCM (25mL). The solution was stirred at −10 ◦C in an ice-methanol bath for 4 hours. 
The organic layer was washed with aqueous sodium sulfite (10% w/v) and sodium 
carbonate (5% w/v) (20 mL, 1:1), was dried and the solvent was evaporated under 
reduced pressure. The compound was obtained by column chromatography, eluting with 
ethyl acetate–hexane (1:3). Removal of the solvent under reduced pressure furnished 
white crystals (594 mg, 1.68 mmol, 80%). 1H NMR (CDCl3, 300 MHz): d 8.17 (d, 1H, J 
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= 9.8 Hz), 7.61 (d, 1H, J =2.3Hz), 7.16 (s, 1H), 6.95 (d, 1H, J =2.3Hz), 6.29 (d, 1H, J = 
9.8 Hz), 5.6 (t, 1H, J = 6.4 Hz), 4.97 (d, 2H, J = 6.4 Hz), 2.73– 2.71 (m, 1H), 2.26–2.22 
(m, 2H), 1.71 (s, 3H), 1.70–1.61 (m, 2H), 1.31 (s, 3H), 1.29 (s, 3H); m/z (EI) 354 (23%, 
M+), 202 (100%). 
(R)-DHB. A mixture of (DHQD)2PHAL (35.0 mg, 0.044 mmol), K2OsO4•2H2O 
(8.1 mg, .022 mmol), K3Fe(CN)6 (4.38 g, 13.32 mmol), K2CO3 (1.84 g, 13.32 mmol), 
CH3SO2NH2 (432 mg, 4.44 mmol), and bergamottin [8] (1.5 g, 4.44 mmol) in 50 mL of 
1:1 t-BuOH-H2O was stirred at 0 °C for 17 h. The reaction was quenched with 10 mL of 
saturated Na2SO3 and 10 mL of saturated Na2S2O3 at 0 °C, and was then allowed to warm 
to 23 °C and stirred for 45 min. After removal of t-BuOH under reduced pressure, the 
reaction mixture was extracted with 3 X 50 mL of ethyl acetate. The combined extracts 
were washed with 25 mL of 1 N NaOH, followed by 25 mL of brine, dried over Na2SO4, 
and concentrated in vacuum. The residue was purified by silica gel chromatography using 
ethyl acetate–hexane (2:1) to give 1.289 g 78% of (R)-DHB (10), [α]D 20  9.87 (c 
1.00,CH2Cl2). 1H NMR (CDCl3, 300 MHz): d 8.18 (d, 1H, J = 9.8 Hz), 7.61 (d, 1H, J = 
2.1 Hz), 7.17 (s, 1H), 6.95 (d, 1H, J = 2.1 Hz), 6.3 (d, 1H, J = 9.8 Hz), 5.6 (t, 1H, J = 6.5 
Hz), 4.97 (d, 1H, J = 6.5 Hz), 3.33 (m, 2H,), 2.37 (m, 1H), 2.16 (d, 2H, J = 3.1 Hz), 1.79 
(s, 3H), 1.71 (s, 1H); 1.48 (s, 1H); 1.21 (s, 3H); 1.17 (s, 3H);  m/z (EI) 372 (17%, M+), 
202 (100%). 
(S)-DHB. A mixture of (DHQ)2PHAL (35.0 mg, 0.044 mmol), K2OsO4•2H2O 
(8.1 mg, .022 mmol), K3Fe(CN)6 (4.38 g, 13.32 mmol), K2CO3 (1.84 g, 13.32 mmol), 
CH3SO2NH2 (432 mg, 4.44 mmol), and bergamottin [8] (1.5 g, 4.44 mmol) in 50 mL of 
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1:1 t-BuOH-H2O was stirred at 0 °C for 17 h. The reaction was quenched with 10 mL of 
saturated Na2SO3 and 10 mL of saturated Na2S2O3 at 0 °C, and was then allowed to warm 
to 23 °C and stirred for 45 min. After removal of t-BuOH under reduced pressure, the 
reaction mixture was extracted with 3 X 50 mL of ethyl acetate. The combined extracts 
were washed with 25 mL of 1 N NaOH, followed by 25 mL of brine, dried over Na2SO4, 
and concentrated in vacuum. The residue was purified by silica gel chromatography using 
ethyl acetate–hexane (2:1) to give 1.36 g 82% of (S)-DHB (11), [α]D 20  -10.91 (c 
1.00,CH2Cl2). 1H NMR (CDCl3, 300 MHz): d 8.18 (d, 1H, J = 9.8 Hz), 7.61 (d, 1H, J = 
2.1 Hz), 7.17 (s, 1H), 6.95 (d, 1H, J = 2.1 Hz), 6.3 (d, 1H, J = 9.8 Hz), 5.6 (t, 1H, J = 6.5 
Hz), 4.97 (d, 1H, J = 6.5 Hz), 3.33 (m, 2H,), 2.37 (m, 1H), 2.16 (d, 2H, J = 3.1 Hz), 1.79 
(s, 3H), 1.71 (s, 1H); 1.48 (s, 1H); 1.21 (s, 3H); 1.17 (s, 3H);  m/z (EI) 372 (17%, M+), 
202 (100%). 
Paradisin A. (1R)-(−)-10-Camphorsulfonic acid (232mg, 1 mmol) was added to a 
stirred solution of epoxybergamottin (9) (354 mg, 1 mmol) in 1,4-dioxane (25 mL) under 
argon and was stirred at rt for 15 min. After a solution of (R)-DHB (10) (372 mg, 1 
mmol) in 1,4-dioxane (5 mL) was added and stirred at rt for 2 h. On completion of the 
reaction (TLC) a few drops of saturated aqueous sodium bicarbonate solution were added  
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Figure 2.1. Isolation scheme of furocoumarins 1, 2, 3 and 4 from grapefruit juice 
concentrates. 
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Figure 2.2. Structure of isolated furocoumarins from grapefruit juice and grapefruit peel 
oil.  
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and the 1,4-dioxane was evaporated under reduced pressure. The residual oil was 
dissolved in DCM (20 mL), and then the organic layer washed with water (2 × 20 mL) 
and dried with sodium sulfate (Na2SO4). Removal of the solvent under vacuum yielded 
translucent oil. The oil was purified by silica gel chromatography using ethyl acetate–
hexane (1:4) to give white crystals (12) (305 mg, 0.42 mmol, 42%). 1H NMR (CDCl3, 
300 MHz): d 8.18 (d, 2H, J = 9.8 Hz), 7.61 (d, 2H, J = 2.1 Hz), 7.17 (s, 2H), 6.95 (d, 2H, 
J = 2.1 Hz), 6.3 (d, 2H, J = 9.8 Hz), 5.6 (t, 2H, J = 6.5 Hz), 4.97 (d, 2H, J = 6.5 Hz), 3.33 
(m, 4H,), 2.37 (m, 2H), 2.16 (d, 4H, J = 3.1 Hz), 1.79 (s, 6H), 1.71 (s, 2H); 1.48 (s, 2H); 
1.21 (s, 6H); 1.17 (s, 6H);   m/z (EI) 726 (5%,M+), 202 (74%) 
 
Results and Discussion 
Concentrated grapefruit juice was diluted and extracted with ethyl acetate. The 
crude extract was purified using silica gel column chromatography as mentioned in 
Figure 2.1.  Further, the compounds (1-4) (Figure 2.2) were obtained in pure form using 
preparative HPLC. The purity of these compounds was analyzed by HPLC. Figure 2.3 
depicts HPLC chromatograms of crude ethyl acetate extract and compounds (1-4). The 
relative retention times of DHB, paradisin A, bergamottin and bergaptol were found to be 
12.16 ± 0.13, 29.38 ± 0.24, 37.44 ± 0.27 and 5.61 ± 0.19 minutes, respectively. The 
retention time for compound (5), which was isolated from grapefruit peel oil was found 
to be 21.11 ± 0.41. All five compounds observed on TLC as a bluish-white fluorescent 
spot under UV light. In addition, compounds (1-5) showed UV absorption maxima at 321 
and 231 nm, indicating the presence of coumarin nuclei. Compounds (1-5) were 
characterized and identified as bergamottin, dihydroxybergamottin, paradisin-A, 
  
23
bergaptol and geranylcoumarin respectively, using 1H and 13C NMR spectra. Chemical 
shifts of the furocoumarins (23, 84, 86) were in accordance with reported values (Tables 
2.1 and 2.2). 13C NMR spectral assignments were confirmed with the help 2D NMR such 
as FLOCK, DQFCOSY, HSQC spectra. 
Furocoumarin derivatives were prepared using the methods outlined in Figure 
2.4, where the initial step was the deprotection of the commercially available starting 
material bergapten [6]. Treatment with boron tribromide (BBr3) in dichloromethane 
(DCM) afforded the phenolic derivative bergaptol [7] in excelent yields. Alkylation under 
conditions previously employed for the coumarins, with geranyl bromide resulted in the 
desired compound bergamottin [8]. Synthesis of the epoxybergamottin [9] was achieved 
by the treatment of [8] with mCPBA in DCM, the reaction was performed at−10 ◦C, 
resulting in the selective epoxidation of the terminal double bond. Generally epoxides are 
readily opened by nucleophiles under both acidic and basic conditions. This allowed the 
use of the epoxide intermediates as a diversification point, theoretically enabling the 
introduction of a cultivar of functional groups. The two enantiomers R and S 6’, 7’-
dihydroxybergamottin [10] and [11], respectively, were prepared from bergamottin [8] 
using the sharpless asymmetric dihydroxylation protocol, in good yields. Subsequent 
treatment of epoxybergamottin [9] and R-DHB [10] with dilute R-10-Camphorsulfonic 
acid resulted in the ring opening of the epoxybergamottin [9] to give Paradisin A [12] in 
moderate yields; the data was corroborated by NMR and MS studies. 
The isolation of bergamottin, paradisin A and paradisin B from grapefruit juice 
was previously reported (84). Wangensteen et al., reported the isolation of epoxy 
bergamottin from grapefruit peel using diethyl ether (86). The dried extract was subjected 
  
24
to flash chromatography to obtain epoxybergamottin along with other compounds. Ohta 
and co-workers reported isolation of paradisin C from grapefruit juice using hexane-ethyl 
acetate extract followed by column chromatography and ODS HPLC separation (87). 
However there is no data on the levels of these compounds in the grapefruits as 
influenced by pre- and post-harvest factors.  
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Figure 2.3. HPLC chromatograms of crude mixture and furocoumarin standards. 
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Figure 2.4.  Reagents, reaction conditions and structural representation of compounds 6-
12. 
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Table 2.1 1H NMR data of compounds (1-5). 
 
C 1 2 3 4 C 5 
6.24 (1H, d, 9.8 Hz); 6.22 (1H,   ) 6.24 3 6.26 (1H, d, 9.9 
Hz) 
6.24 (1H d, 
9.8 Hz) 6.26 (1H, d, 9.5 Hz)  
3 
 
4 8.05 (1H, d, 9.9 
Hz) 
8.12 (1H, d, 
9.8 Hz) 
8.05 (2H, d, 9.5 Hz) 8.22 (1H,   ) 4 7.63 
5    11.28 (-OH, ) 5 7.36
8 6.74 (1H, s) 7.10 (1H, s) 7.02 (2H, s) 7.11 (1H, ) 8  
11 6.74 (1H, d, 2.5 
Hz) 
6.93 (1H, d, 
2.0 Hz) 
7.07 (2H, d, 2.3 Hz) 7.18 (1H, ) 11  
12 7.55 (1H, d, 2.2 
Hz) 
7.57 (1H, d, 
2.0 Hz) 
7.85 (1H, d, 2.3 Hz) 7.88 (1H,  ) 12  
4.65 (2H, d, 6.5Hz);   13 4.96 (2H, d, 6.6 
Hz) 
4.91 (2H, d, 
6.5 Hz) 4.63 (2H, d, 2.3 Hz)  
13 
 
14 5.50 (1H, t, 6.8 
Hz) 
5.56 (1H, t, 
6.5 Hz) 
5.35 (1H, t); 5.38 
(1H, t) 
 14  
16 1.67 (3H, s) 1.68 (3H, s)   16  
18 2.07 (2H,m) 2.29 (2H, m)   18  
19 1.95 (2H, m ) 3.30 (1H, t)   19  
21 1.65 (3H, s) 1.18 (3H, s) 1.18 (3H, s)  21  
22 1.58 (3H, s) 1.14 (3H, s) 1.33 (3H, s)   22   
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Table 2.2 13C NMR data of compounds (1-5). 
 
C 1 2 3 4    C 5 
2 161.5 161.6 160.5* 160.5 2 161.41 
3 112.5 112.5 112.4* 111.01 3 113.05 
4 139.7 139.9 138.6; 
138.4** 
139.79 4 143.57 
5 149 148.9 149.0* 147.71 5 128.79 
6 118.9 119.3 117.9; 
118.4** 
112.468 6 113.35 
7 158.2 158.2 157.7* 157.08 7 162.27 
8 94.2 93.3 93.8* 91.07 8 101.71 
9 152.7 152.6 151.6* 152.68 9 155.98 
10 107.5 107.5 106.9* 103.718 10 112.54 
11 105.2 105.1 105.1* 104.73 11 65.61 
12 145 145.1 144.6* 145.02 12 118.54 
13 69.8 69.7 66.8; 
66.7** 
13 142.46 
14 114.3 114.2 114.3* 14 39.62 
15 143.1 143 142.8; 
142.6** 
15 26.35 
16 16.8 16.7 17.01; 
16.9** 
16 123.73 
17 39.6 36.5 34.5; 
36.6** 
17 132.06 
18 26.3 29.5 29.3; 
35.9** 
18 17.82 
19 123.6 73.1 82.5; 
77.8** 
19 25.76 
20 132.1 77.9 71.6; 
76.5** 
20 16.87 
21 17.8 23.3 25.8; 
21.1** 
 
 
22 25.8 26.6 27.7; 
27.5** 
  
   
 
*     Showed one signal for two carbons 
**   Two chemical shifts in the same row for two carbons in dimer unit for the 
corresponding carbon 
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CHAPTER III 
INFLUENCE OF PRE-HARVEST FACTORS ON FUROCOUMARIN LEVELS 
IN GRAPEFRUITS  
 
Synopsis 
Variation of three furocoumarins such as dihydroxybergamottin, paradisin A and 
bergamottin were quantified in seven cultivars of grapefruits and its parent Pummelo. 
The changes in the levels of these compounds due to season and location were also 
monitored during the season and the effect of location, using high performance liquid 
chromatography. Considerable differences were observed in the levels of these 
compounds in different grapefruit cultivars. Ray Red showed the lowest levels of all three 
furocoumarins (0.492 ± 0.027 µg/mL DHB, 0.059 ± 0.001 µg/mL paradisin A and 0.344 
± 0.030 µg/mL bergamottin) and Duncan showed the highest amount of DHB (2.587 ± 
0.432 µg/mL) and bergamottin (1.004 ± 0.068 µg/mL), where as the highest levels of 
paradisin A was observed in Star Ruby. The levels of both DHB and bergamottin in both 
cultivars of grapefruit decreased as the season progresses except for the bergamottin in 
Marsh White grapefruit. Influence of growing location, processing and storage on the 
levels of these compounds was also evaluated.  Among the cultivars the highest levels of 
DHB (2.266 µg/mL) and bergamottin (2.411 µg/mL) were found in Flame grapefruit. 
The highest level of paradisin A was found in Rio Red grapefruit grown in California and 
the lowest levels were observed in Rio Red grapefruit grown organically in Texas. 
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Introduction 
 
The phytochemical profile of the citrus fruit varies with cultivar, environmental 
conditions and the stage of fruit development and maturity. Duncan and Marsh White 
showed variation in naringenin (70) and limonin content (71). Grapefruit trees exposed to 
freezing conditions showed more naringin and less limonin (72). Other environmental 
stress parameters such as temperature and humidity affected the levels of naringin (73, 
74). Bioactive compound levels changes during developmental stages.  Furthermore, 
highest concentration of naringin (74, 75), limonin (76) and nomilin (77) were observed 
at early developmental stages and progressively declined as fruit matured. 
The content of certain bioactive furocoumarins in grapefruit juice can vary 
considerably. Tassanyakula and his group reported four fold variations of bergamottin, 
43- fold variations of DHB and 65- fold variations of dimers in the commercial grapefruit 
juice (79). Fresh squeezed grapefruit juice increased the bioavailability of terfanadine 
more than twofold compared to industrially-processed juice (17). Fukuda et al., (78) 
reported that furocoumarins levels in white were higher than red commercial grapefruit 
juices. Furthermore, the highest levels of furocoumarins were found in the fruit meat 
(78).  While environmental factors may have influence on furocoumarins and flavonoids, 
genetic factors might play a major role in variation of these bioactive compounds. 
Variation and quantification of furocoumarins reported so far involve commercially 
processed juice. During processing, juice undergoes high temperature treatment and some 
of the fruit components such as pulp are removed while essential oils are added back to 
the finished juice. Thus, the objective of this study was to determine the levels of specific 
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furocoumarins content in different fresh grapefruit cultivars and from different locations 
and also changes during season.  
 
Materials and Methods 
Cultivar Study.  Seven grapefruit cultivars such as Rio Red, Ruby Red, Ray Red, 
Star Ruby, Thompson Pink, Marsh White, Duncan and grapefruit parent Pummelo were 
harvested in the month of February 2005 from an orchard at the Texas A&M University-
Kingsville Citrus Center Weslaco, Texas.  
Seasonal Study. Rio Red and Marsh White grapefruits were harvested from an 
orchard at the Texas A&M University-Kingsville Citrus Center, Weslaco, Texas. The 
fruits were harvested at 30 days interval starting form the month of November 2003 to 
May 2004. The fruits were juiced and stored at -80 ºC until analyzed for the 
furocoumarins levels.  
Location Study. In the month of March, Rio Red grapefruits were collected from 
Texas, Florida and California while. Marsh White grapefruits were collected from only 
two states Florida and Texas. Fruits were shipped from Florida and California through 
overnight mail.  Fruits were juiced and analyzed for the levels of furocoumarins 
immediately after receiving the shipment.  
Chemicals and HPLC Analysis. All the solvents for extraction and isolation 
were ACS grade and for quantitative analysis HPLC grade were obtained from EMD 
(EMD Chemicals Inc., Gibbstown, NJ). HPLC analyses were performed as described in 
chapter II. 
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Standard Furocoumarins and Standard Curve. Furocoumarins were isolated 
and characterized as described in chapter II. Isolated compounds were used as standards 
for quantification. Standards of DHB, paradisin A and Bergamottin were weighed and 
dissolved in 1 mL of methanol to give serial concentrations. Three injections were 
performed for each dilution. The standard curve was by plotting concentration against the 
peak area. 
Sample Preparation for Furocoumarins. Samples stored at -80 ºC were thawed 
to room temperature and 50 mL of juice was taken in a 250 mL separating funnel 50 mL 
of ethyl acetate was added and mixed well for 5 minutes. The organic layer was separated 
carefully, and then this step was repeated twice. Extracts of each sample were pooled and 
the ethyl acetate was evaporated to dryness under vacuum using Buchi rotary 
evaporators. Extract was reconstituted in HPLC grade methanol for HPLC analysis. 
Statistical Analysis. The amounts listed are averages of 15 samples. Dunnett’s 
multiple comparisons test was used to determine the significance at P < 0.005. Analysis 
was performed using GraphPad Instat version 3.00 for windows. Mean values and 
standard deviations (SD) were reported. 
 
Results and Discussion 
 
Calibration. A calibration curves for furocoumarins and flavonoids were derived 
from three injections of different concentrations with good reproducibility and accuracy. 
Regression equations were obtained with correlation coefficient of ≥ 0.99.  
Variation of Furocoumarins in Different Cultivars of Grapefruits. 
Bergamottin and Figures 3.1, 3.2 and 3.3 demonstrates the levels of three furocoumarins 
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in seven different cultivars of grapefruits and Pummelo. DHB levels showed more 
variation among grapefruit cultivars than paradisin A. The highest levels of DHB were 
found in Duncan (2.587 ± 0.092 µg/mL) while the lowest levels were found in Ray Red. 
In general, red and pink cultivars contain more DHB than the white cultivars while 
Pummelo was on par with the colored cultivars. The order of paradisin A content was 
found to be Star Ruby > Ruby Red > Marsh White > Pummelo > Duncan > Rio Red > 
Thompson Pink > Ray Red. There was no significant difference of paradisin A content 
between the colored and white cultivars. The highest levels of bergamottin were found in 
Duncan and lowest levels were found in Ray Red. Pummelo showed higher bergamottin 
levels compared to different grapefruit cultivars.  
Available information on separation, quantification and variation was on 
commercial grapefruit juices. There is vast difference between fresh juice and 
commercially processed juice as some of the fruit components are removed, modified, 
added partially or fully back into the finished product. And also as juice undergoes 
physical treatments such as high temperature treatment and mechanical pressure which 
may influence these compounds. It is evident from this study that grapefruit cultivars 
differ in its bioactive furocoumarins contents.  
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Figure 3.1. DHB found in the seven grapefruit cultivars and Pummelo. Cultivars used 
were RIO (Rio Red), RUB (Ruby Red), RAY (Ray Red), STA (Star Ruby), THO 
(Thompson Pink), MAR (Marsh White), DUN (Duncan) and PUM (Pummelo). The data 
are shown as the mean of ± S.D. n=15 samples. 
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Figure 3.2. Paradisin A found in the seven grapefruit cultivars and Pummelo. Cultivars 
used were RIO (Rio Red), RUB (Ruby Red), RAY (Ray Red), STA (Star Ruby), THO 
(Thompson Pink), MAR (Marsh White), DUN (Duncan) and PUM (Pummelo). The data 
are shown as the mean of ± S.D. n=15 samples. 
 
 
 
 
 
 
 
 
  
36
 
 
 
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
RIO RUB RAY STA THO MAR DUN PUM
Varieties
C
on
ce
nt
ra
tio
n 
of
 b
er
ga
m
ot
tin
(µ
g/
m
l)
 
 
 
 
Figure 3.3. Bergamottin found in the seven grapefruit cultivars and Pummelo. Cultivars 
used were RIO (Rio Red), RUB (Ruby Red), RAY (Ray Red), STA (Star Ruby), THO 
(Thompson Pink), MAR (Marsh White), DUN (Duncan) and PUM (Pummelo). The data 
are shown as the mean of ± S.D. n=15 samples. 
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Seasonal Variation of DHB, Paradisin A and Bergamottin.  Furocoumarins are 
phytoalexins produced perhaps in response to external stimuli such as stress or 
pathogenic infection. At any given time the level of these compounds reflect the 
physiological condition of the plant. DHB levels were highest in the beginning of the 
season and showed decreasing trend till the end of the season with 1.171 and 1.675 
µg/mL in Rio Red and Marsh White cultivars, respectively (Figure 3.4-3.6). There was 
43.21 % and 39.82% decrease in the concentration of DHB from the beginning of the 
season to the end of the season in Rio Red and Marsh White grapefruit. Throughout the 
season, Marsh White contains more DBH than Rio Red. Marsh White had 30.08% and 
34.02% more DBH than Rio Red at the beginning and end of the season, respectively. 
Paradisin A, a dimer probably derived from DHB by a dehydration reaction, is distributed 
10 to 15 times lower than DBH. Paradisin A concentrations were 91 and 87 ng/mL at the 
beginning of the season and 81 and 76 ng/mL at the end of the season in Rio Red and 
Marsh White, respectively. There is no particular trend in the distribution of the paradisin 
A during the season as seen in case of DHB. However, paradisin A is potent inhibitor of 
CYP3A4 than DHB and bergamottin (42). The magnitude is several folds higher than 
both monomers together, indicating the potential of paradisin A to be highly active even 
in at low concentration. Bergamottin is probably precursor of DHB in the furocoumarins 
biosynthesis. The concentration of bergamottin showed decreasing trend from the 
beginning of the season to the end, among the two cultivars Marsh White contains 
average of 35.58% more bergamottin than Rio Red.    
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Figure 3.4. Influence of season on the level of DHB in Rio Red and Marsh White 
grapefruit juice. The data are shown as the mean of ± S.D. n=15 samples. 
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Figure 3.5. Influence of season on the level of paradisin A in Rio Red and Marsh White 
grapefruit juice. The data are shown as the mean of ± S.D. n=15 samples. 
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Figure 3.6. Influence of season on the level of bergamottin in Rio Red and Marsh White 
grapefruit juice. The data are shown as the mean of ± S.D. n=15 samples. 
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Influence of Location and Cultivation Method on the Levels of 
Furocoumarins. Due the lack of availability of the tested grapefruit cultivars in all three 
locations, only two cultivars were compared for growing location study. Marsh White 
grown in Texas contain 32.15% higher DBH compared to the same cultivar grown in 
Florida (Figure 3.7). While significantly higher levels of bergamottin were observed 
when Marsh White grapefruit was grown in Florida compared to the same cultivar grown 
in Texas, no differences of paradisin A were observed in between both locations. 
Interestingly, among the three growing locations, when Rio Red grown in California, 
Texas and Florida, DHB levels were significantly higher in fruits grown in California 
compared the same grapefruit grown in Texas and Florida.  Furthermore, Rio Red 
grapefruit grown in Florida had significantly higher paradisin A compared to the same 
grapefruit grown in Texas and California while there is no differences in the levels of 
bergamottin were observed among the three locations (Figure 3.8, 3.9).  
Rio Red grapefruit grown using conventional practices were compared with the 
same cultivar grown organically.  DHB levels were higher in Rio Red grapefruit grown 
with conventional practices compared the same cultivar grown organically (Table 3.1), 
while paradisin A levels were more in organically grown grapefruit compared 
conventionally grown grapefruit.  No significant differences were observed in the levels 
of bergamottin levels in Rio Red grapefruit grown with conventional and organic 
practices. Among the grapefruit cultivars grown at different locations, Flame grapefruit 
from Florida had the highest concentration of DHB, bergamottin and paradisin A, while 
lowest levels of DHB and paradisin A were observed in organically grown Rio Red 
grapefruits (Table 3.1). 
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Table 3.1. Influence of cultivation method and cultivar on the levels of furocoumarins in 
grapefruit. 
 
Grapefruit Furocoumarins levels (µg/mL) 
  DHB Paradisin A Bergamottin 
Rio Red- Conventional 0.989 ± 0.115a 0.0910 ± 0.004 0.754 ± 0.057 
Rio Red- Organic  0.627 ± 0.061 0.0669 ± 0.014 0.774 ± 0.074 
Flame- Florida 2.266 ± 0.113 0.2089 ± 0.004 2.411 ± 0.116 
Melgold- California 2.129 ± 0.068 0.0794 ± 0.012 1.451 ± 0.118 
 
aMean ± standard deviation, n=15. 
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Furocoumarins are phytoalexins produced perhaps in response to external stimuli 
such as stress or pathogenic infection (43). At any given time the level of these 
compounds reflect the physiological condition of the plant. A considerable proportion of 
furocoumarins may be recovered from surface of plants (44). The concentration of three 
furocoumarins such as xanthotoxin, bergapten and psoralen were measured by Zobel and 
Brown in whole leaves of Heracleum lanatum and in the extracts of leaf over vegetative 
season. Furocoumarins concentration in the whole leaf varied, with highest being in the 
month of April and sharp decline afterwards as leaf enlarged rapidly (44). It has been 
previously shown that celery grown near urban centers in California was found to 
stimulate accumulation of psoralen, bergapten, xanthotoxin and isopimpinellin (88). 
Genetic make up such as cultivar/cultivar, environmental conditions, developmental stage 
of plant also influence the content of plant secondary metabolites. De Castro et al., 
reported considerable variability of naringin, bergamottin and DHB in grapefruit juice 
with several fold variation between the juice different juice preparations (89). In another 
study by Ho et al reported 1.5, 2.3 and 4.7 fold variation in the content of naringin, 
naringenin and bergapten, respectively in different lots of grapefruit juice preparations in 
New Zealand (90). Guo et al reported the 43 fold variation of DHB, 14 fold variations for 
paradisin A and 4.1 fold variation for bergamottin in different juices (42). 
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Figure 3.7. DHB levels in Rio Red and Marsh White grapefruits grown at different 
locations. The codes in the panel (RRT) Rio Red –Texas, (RRF) Rio Red –Florida, 
(RRC) Rio Red –California, (MWT) Marsh White –Texas and (MWF) Marsh White –
Florida. Data shown are the mean ± SD for 15 samples.  
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Figure 3.8. Paradisin A levels in Rio Red and Marsh White grapefruits grown at different 
locations. The codes in the panel (RRT) Rio Red –Texas, (RRF) Rio Red –Florida, 
(RRC) Rio Red –California, (MWT) Marsh White –Texas and (MWF) Marsh White –
Florida. Data shown are the mean ± SD for 15 samples. 
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Figure 3.9. Bergamottin levels in Rio Red and Marsh White grapefruits grown at 
different locations. The codes in the panel (RRT) Rio Red –Texas, (RRF) Rio Red –
Florida, (RRC) Rio Red –California, (MWT) Marsh White –Texas and (MWF) Marsh 
White –Florida. Data shown are the mean ± SD for 15 samples. 
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CHAPTER IV 
INFLUENCE OF POST-HARVEST FACTORS ON FUROCOUMARIN AND 
OTHER BIOACTIVE COMPOUNDS OF GRAPEFRUIT 
 
Synopsis 
Several post-harvest factors such as processing, storage, quarantine treatments 
have potential impact on the levels of bioactive compounds of grapefruit. Rio Red and 
Marsh White grapefruits were irradiated with E-beam at 0, 1.0, 2.5, 5.0 and 10.0 KGys. 
The dose effect of E-beam on levels of various bioactive fruit components such as 
vitamin C, flavonoids, carotenoids, furocoumarins and limonoids, were monitored. 
Quality parameters such as appearance, taste and acceptability were evaluated. Results 
showed that the irradiation does not affect the vitamin C content at 1KGys. However, 
doses beyond 1 KGys drastically reduce the vitamin C. Both carotenoids (lycopene and 
β-carotene) respond differently to the irradiation. The levels of DHB showed decreasing 
trend while bergamottin content did not change. Naringin a major flavonoid of grapefruit 
showed significant increase over the control at 10KGys in Rio Red and Marsh White. 
Nomilin showed decreasing tend with increase in dose while limonin remained same in 
all the doses. Likeness of appearance and taste were influenced differently at different 
doses. One KGys was shown to improve the appearance and organoleptic quality while at 
10KGys had significant decrease in the taste and organoletic qualities in both cultivars. 
Hand squeezed juice contained 1.98, 1.06 and 3.03 fold more DHB, paradisin A and 
bergamottin, respectively as compared to processed juice. The levels of furocoumarins 
showed a decreasing trend in all the juices with progress of storage. Levels of 
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furocoumarins were more in cartoon containers than the cans and cardboard container 
juices. 
 
Introduction 
Ionizing radiation is the most effective technique that inactivates human 
pathogens and reduces the spoilage of fruit juices and other foods (91-93). The number of 
food items approved for irradiation is increasing at the global level. Food and Drug 
Administration in the United States approved low –level irradiation of food and food 
products to reduce the incidence of illness resulting from pathogenic microorganisms 
(94). Food irradiation with doses even >10 kGys was endorsed by a joint 
FAO/IAEA/WHO study group (95). In fact, irradiation, commonly referred to as cold 
pasteurization, is less environmentally and nutritionally harmful than most other 
traditional practices. However, irradiation can reduce the food quality by developing off-
odors and flavors (96). 
The content of bioactive compounds in fruits and vegetables may be altered by 
post harvest treatments such as irradiation, storage and freeze drying conditions (97). 
Thus the objective of this study was to evaluate the effect E-beam irradiation, γ-
irradiation, processing and storage on furocoumarins found in grapefruit juice.  
 
Material and Methods 
Samples. Rio Red and Marsh White grapefruits were harvested from an orchard 
at Texas A&M University Kingsville Citrus Center, Weslaco Texas, during the month of 
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December 2005. Fruits were juiced using blenders after irradiation and stored at -80 ºC 
until analyzed for various parameters.  
E-beam Source and Dose Calculations. Rio Red and Marsh White grapefruits 
were subjected to ionizing radiation ranging from 0 (non-irradiated control) to 10 kGys 
using a 2.0 MeV Van der Graff Electron Accelerator (High Voltage Engineering 
Cooperation) located at the National Center for Electron Beam Food Research, Texas 
A&M University, College Station, Texas. Absorbed dose was determined from the count 
of C × 10-8 coulombs in the Van der Graff and related with dose previously determined 
with a Farmer Dosimeter (J.L. and associates, Glendale CA, USA) placed on the top and 
bottom of the fruits when the fruits were irradiated (Figure 4.1). The time dose 
application was recorded using a stopwatch (Fisher Scientific, Canada).  The dose was 
adjusted accordingly to treat the fruit samples with 1, 2.5, 5 and 10 KGys. Ten pounds 
(per treatment) of fruits were packed in 5 inch cardboard boxes and irradiated with above 
doses of ionizing radiation (E-beam).  
γ-irradiation and Dose Calculations. Rio Red and Marsh White grapefruits were 
subjected to γ-irradiation ranging from 0 (non-irradiated control) to 2.4 KGys using self 
contained dry storage units of 137Cs (Husman model 521A, Inc., Whippany, NJ) at the 
USDA facility Mission, Texas. The non-irradiated control fruits were also transported to 
the irradiation facility along with the samples to be irradiated to expose them to the 
similar conditions. 
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Figure 4.1. Design and placement of grapefruit boxes for irradiation treatments using a 
2.0 MeV Van der Graff linear accelerator at room temperature.  
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Post-Harvest Storage Study. Rio Red and Marsh White grapefruits were packed 
in to boxes (total of 36 numbers), separately, each box contained 12-15 fruits. Boxes 
were stored at two storage conditions. One was at 24 ºC and another was at 9 ºC with 
relative humidity between 90-95%. Every two weeks, fruit samples were analyzed for 
furocoumarin levels. Total of four samplings were taken for the grapefruits stored at 9 ºC. 
However, for fruits stored at 24 ºC, only three samplings were taken as fruits desiccated 
after 30 days. Grapefruits were juiced using blender and juice was analyzed for 
furocoumarins content. 
  Juice Storage Study. Three single strength commercial Rio Red grapefruit juice 
products, such as cans (100% juice from concentrate), cartoons (100% pure fresh juice 
and not from concentrate, can be stored for 60 days at refrigerated condition) and 
cardboards (100% juice from concentrate) were obtained from Texas Citrus Exchange, 
Mission, TX, USA. Total of 25 cans and cardboard containers and 20 cartoon containers 
were used for the storage study. Cans and cardboard containers were stored at room 
temperature while cartoon containers were stored at refrigerated conditions, simulating 
the grocery store conditions. Cans and cardboard containers were stored for 75 days 
while cartoon containers were stored 60 days and every 15 days five containers were used 
for analysis.   
Processing of Juice. In order to determine the effect of processing on 
furocoumarins, a separate experiment was conducted at industrial scale level. The Rio 
Red grapefruits were harvested from the Texas A&M University-Kingsville Citrus Center 
at Weslaco and grouped into two batches. One batch of fruits from two bins of fruits were 
juiced in the lab and the other batch containing 48 bins of fruits were processed at Texas 
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Citrus Exchange commercial juice plant under commercial processing conditions. 
Sequence of events in the processing of grapefruits include i) washing the fruits, ii) 
puncturing the fruits to obtain peel oil, iii) mechanical cutting of fruits into two halves, 
iv) juicing the halves by automated juicers, v) removing the pulp by straining the juice, 
vi) pasteurizing the juice and vii) automated packing of the juice into cans. Both types of 
juices were stored at room temperature until sampled for analysis. 
Standards. Ascorbic acid, lycopene, β-carotene, naringin and naringenin were 
purchased from Sigma chemical Co. (St. Luis, MO, USA). Dihydroxybergamottin, 
bergamottin, limonin and nomilin were purified according to published method (98).  
Determination of Acidity and Total Soluble Solids. Acidity of juice samples 
were measured by an Acuumet pH reader (Fisher Scientific Pittsburgh PA, USA) and 
total soluble solids were measured using a hand refractometer (American Optical 
Corporation Buffalo NY, USA). 
Standard Curve. Stock solutions (3.90, 7.81, 15.62, 31.25, 62.5, 125, 250, 500, 
and 1000 PPM) of vitamin C and carotenoids (lycopene and β-carotene) were prepared in 
milli Q water and chloroform respectively. Stock solutions (3.90, 7.81, 15.62, 31.25, 
62.5, 125, 250, 500, and 1000 PPM) of limonin and nomilin were prepared in acetone. 
Elution was carried out to obtain peak area responses. The calibration curves for each 
compound were prepared by plotting concentration of each compound versus peak area. 
Determination of Vitamin C. Two mL of grapefruit juice was mixed with 10 mL 
of 3% metaphosporic acid and homogenized for 5 minutes. The homogenate was filtered 
through filter paper. An aliquot of one mL was filtered through 0.45 µm membrane filter 
(Pall Corporation Ann Arbor, MI USA). Twenty microliters of one mL aliquot sample 
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was injected into HPLC system.   Alltech Alphbonda Amino 10µ C-18 column (300 x 
3.9) was used for the separation and quantification. The mobile phase used was 
acetonitrile:water (70:30 v/v) with 1.15 g/L of (NH4)H2PO4 at a flow rate of 1 mL/min. 
Vitamin C peak was detected at 255 nm with retention time of 6.49 ± 0.04 min. 
Determination of Carotenoids. Ten mL of grapefruit juice was mixed with 50 
mL of acetone and mixed well. Five mL of hexane and 50 mL of water was added to the 
mixture. The hexane layer was separated and dried with nitrogen and a one mL sample 
was prepared with acetone and filtered with 0.45 µm membrane filter. Ten microliters of 
extract was loaded on to Waters Sperisorb ODS-2 5µm column (250 X 4.6 mm). Elution 
was carried out with mobile phase containing solvent A (35% of ethyl acetate in 
acetonitrile) and B (ethyl acetate with 1mL of TEA/liter). Lycopene and β-carotene were 
detected at 450 nm with peak retention times at 7.73 and 10.69 minutes respectively. 
Determination of Furocoumarins and Flavonoids. Furocoumarins were 
determined according the methods as described in chapter II. 
Determination of Limonoid Aglycones. Juice was extracted with ethyl acetate 
and 50 µL of extract was injected on to Geminai (Phenomenex Torrance CA, USA) 
column and eluted with acetnitrile (C) and water (D) as follows: 0 min A, C 20%; 20 
min, C 35%; 40min, C 42%; 50 min, 55%; 55 min, A 100%; 57 min, A 100%; 60 min, A 
20%. The flow rate was set at 1 mL/min and elution was monitored at 210 nm with a 
photodiode array detector. 
  Quality, Taste and Flavor Evaluation. Control and irradiated fruits were 
evaluated for consumer acceptability by 23 untrained panelists at Vegetable and Fruit 
Improvement Center Texas A&M University College Station. Preference evaluation was 
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conducted to determine the appearance, taste and flavor. Quantitative preference rating 
(American Society for Testing and Material, 1968) was used to evaluate ratings for 
appearance, taste, flavor and organoleptic properties. Five fruits of each Rio Red and 
Marsh White were presented for appearance evaluation. Eight slices were prepared from 
each fruit total of five fruits were presented for flavor and taste analysis. Panel was asked 
to mark on the hedonic scale ranging from extremely dislike to extremely like (1-10 cm 
scale line) according to their feel and preference. Results from 1 -10 scale were converted 
to percentile. 
 
Results and Discussion 
Influence of E-beam on Acidity and Total Soluble Solids. Figure 4.2 shows 
the effect of E-beam on acidity and total soluble solids of Rio Red and Marsh White 
grapefruit juice. As doses increased, acidity of the juice decreases and total soluble solids 
increased slightly, compared to control. 
Influence of E-beam on Vitamin C Content. Figure 4.3 shows the levels of 
vitamin C in different treatments of E-beam irradiated Rio Red and Marsh White 
grapefruit juice. Vitamin C concentration in Rio Red at 1 KGys treatment showed 0.77% 
decrease in Marsh White and 1.26% in Rio Red. As the dose of the irradiation increased, 
the level of vitamin C decreased considerably. Remarkable decrease was observed at 10 
KGys in both the cultivars of juices; Rio Red showed a 53.52% decrease while Marsh 
White showed a 50.03% decrease in total vitamin C concentration. Vitamin C in several  
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Figure 4.2. Effect of E-beam irradiation on A) acidity, B) total soluble solids of Rio  
Red and Marsh White grapefruit. 
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Figure 4.3. Effect of E-beam irradiation on vitamin C levels of Rio Red and Marsh 
White grapefruit. 
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citrus fruits undergoes degradation during processing, storage (99, 100) and is affected by 
storage length, conditions and temperature (101, 102). Oxidation of ascorbic acid 
proceeds both aerobic and anaerobic pathways and depends upon several factors, 
including oxygen, heat and light (103). Degradation products of vitamin C along with 
amino acids lead to the formation of brown pigments, which is another problem of 
quality loss in citrus juices during storage (104). 
Influence of E-beam on Carotenoids. Figure 4.4 shows the concentration of 
lycopene and β-carotene in the Rio Red and Marsh White grapefruit juices influenced by 
E-beam irradiation at different doses; both lycopene and β-carotene were not detected in 
Marsh White grapefruit juice. Lycopene concentrations decreased by 2.98% and 12.33% 
at 1KGy and 10 KGys respectively compared to those of untreated fruit. Conversely, β-
carotene levels showed an increase in concentration. There was a 0.14% and 0.39 % 
increase in the β-carotene concentration at 1KGys and 10 KGys, respectively. Studies 
have shown that lycopene content of late season fruit was significantly lower than early 
season fruit (105), especially from October to May (106). Fruit pulp attains the highest 
color early in the season and decreases as the season progresses (107). Gamma irradiation 
doses of 10 KGys and 20 KGys did not affect β-carotene levels (108). Previous studies 
have demonstrated that, irradiation, freeze drying, season and storage affect the 
carotenoids content (96) and freeze drying alone can reduced the β-carotene up to 30%. It 
has been shown that plants respond to oxidative stress by increasing the levels of 
antioxidants such as carotenoids and also by increasing some antioxidant enzymes (109).  
 
 
  
58
 
 
 
 
Figure 4.4. Effect of E-beam irradiation on A) lycopene, B) β-carotene levels of Rio Red 
grapefruit. 
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Figure 4.5. Effect of E-beam irradiation on A) DHB, B) Bergamottin levels of Rio Red 
and Marsh White grapefruit. 
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Figure 4.6. Effect of E-beam irradiation on naringin levels of Rio Red and Marsh White 
grapefruit. 
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Figure 4.7. Effect of E-beam irradiation on A) nomilin, B) limonin levels of Rio Red and 
Marsh White grapefruit. 
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Influence of E-beam on Furocoumarins. Figure 4.5 shows the effect of E-beam 
irradiation on dihydroxybergamottin and bergamottin concentration. DHB levels show a 
decreasing trend from 1KGy to 10 KGys in both the cultivars. Rio Red fruits exposed to 
1 KGys showed a 10.21% decrease over the control, while juice exposed to 10 KGys 
showed a 29.87% decrease. Marsh White showed 2.23% and 20.54% decrease at 1 and 
10 KGys doses. However, bergamottin levels showed very little changes due to E-beam 
treatment.  
Influence of E-beam on Flavonoids. Figure 4.6 shows the levels of naringin in 
Rio Red and Marsh White as influenced by e beam irradiation. Concentrations of 
naringin show an increasing trend in both the cultivars. There was a 4.96% and 4.93% 
increase over control at 1KGys and 10 KGys doses increased 18.90% and 15.37% 
increase in Rio Red and Marsh White, respectively. Naringin is the major flavonoid 
component responsible for grapefruit juice bitterness. Irradiation has been shown to 
increase the phenylalanine ammonia lyase (PAL) activity in citrus and other fruits (110, 
111). PAL enzyme catalyzes the deamination of L-phenylalanin to form trans- cinnamic 
acid, a precursor for flavonoids and tannins (112). Irradiation induced de novo synthesis 
of naringin by PAL may be responsible for the increase in the content of naringin in 
treatments over the control.  
Influence of E-beam on Limonoid Aglycones (Limonin and Nomilin). Figure 
4.7 shows the effect of irradiation on the concentration of limonin and nomilin in Rio Red 
and Marsh White grapefruit juices. Nomilin showed decrease in concentration with 
increase in dose. At 1KGy treatment, nomilin decreased by 7.19% and 4.27%, where as 
10KGys reduced the concentration by 19.02% and 21.56% in Rio Red and Marsh White  
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Figure 4.8. Effect of E-beam irradiation on A) appearance, B) taste of Rio Red and 
Marsh White grapefruit. 
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juices, respectively. In contrast limonin did not show significant change in the 
concentration with irradiation treatment. Vanamala et al., reported that the gamma-
irradiation coupled with freeze drying is shown to influence limonoid aglycones; limonin 
and nomilin decreased by 15% and 47% respectively, however no significant difference 
was observed for obacunone concentration (96). 
Influence of Irradiation on Appearance and Taste. Figure 4.8 shows the effect 
of E-beam irradiation on appearance and taste of Rio Red and Marsh White grapefruits. 
Results from informal, untrained panel evaluation showed that 1KGys dose improved the 
appearance of fruits in both Rio Red and Marsh White grapefruits. There was 24.56% and 
5.25% increase in appeal for 1KGys irradiated fruits over control for Rio Red and Marsh 
White respectively. However, at 10 KGys, a considerable decrease in appearance was 
noticed; the panel rated Rio Red and Marsh White 24.86% and 75.31% lower than 
control. In taste analysis of fruits exposed to 1KGy of irradiation, Rio Red was ranked 
4.91% lower than control while Marsh White was ranked 16% higher. However, both 
grapefruit cultivars fruits were ranked lower in taste at 10 KGys. The taste rating of Rio 
Red decreased 73.03% and Marsh White decreased 80.20%, a significant drop compared 
to control. 
Influence of γ-irradiation on Furocoumarins. Figure 4.9-4.11 shows the effect 
of γ-irradiation on dihydroxybergamottin, paradisin A and bergamottin concentration in 
Rio Red and Marsh White grapefruit. All the three furocoumarins showed decreasing 
levels in the juice as the dose of the irradiation increased. Paradisin A concentration 
change was prominent among the three, with 66.66% and 67.88% decrease in Rio Red 
and Marsh White cultivars. 
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Processing Effects on Furocoumarins Levels. Figure 4.12 depicts the levels of 
furocoumarins in hand squeezed and commercially processed grapefruit juices. Results 
indicate that DHB and bergamottin content were 1.98 and 3.03 times higher in hand 
squeezed juice than processed juice, respectively.   The levels of paradisin A were not 
significantly (P < 0.005) different between hand squeeze and commercially processed 
juices. 
Post-Harvest Storage Influence on Furocoumarins Levels. The levels of 
furocoumarins decreased quite remarkably in both cultivars stored at 24 ºC and   9 ºC 
(Table 4.1).  The DHB concentrations were decreased by 8.57% and 20.34% in Rio Red, 
while decrease was by 7.37% and 16.15% in Marsh White when the fruits were stored at 
9 ºC and 24 ºC, respectively. The most pronounced decrease (30.43%) was noticed for 
paradisin A in Rio Red stored at 24 ºC. Bergamottin was relatively stable compound in 
both temperatures, with decrease of 4.14%, 12.16 % in Rio Red and 2.86% and 2.93% in 
Marsh White at 9 ºC and 24 ºC, respectively. In general, bergamottin was more stable 
during post -harvest storage followed by DHB and paradisin A. 
Table 4.2 depicts the levels of three furocoumarins in three kinds of processed 
juice in containers such as cans, cardboard and cartoons. The levels of furocoumarins 
showed a decreasing trend in all three types of container as the storage time is extended. 
Levels of furocoumarins were higher in cartoon containers, compared to other containers. 
The levels of DHB, paradisin A and bergamottin were 2.065 ± 0.081, 0.099 ± 0.044 and 
1.255 ± 0.028 µg/mL, respectively at the beginning of the study. After 90 days of storage 
levels of the furocoumarins decreased by 31.67%, 43.43% and 11.31% of DHB, paradisin 
A and bergamottin, respectively compared to the beginning of the season.  The levels of 
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DHB, paradisin A and bergamottin in cardboard containers decreased by 33%, 57% and 
32%, respectively over a period of 90 days.  However, DHB, paradisin A and 
bergamottin were 24%, 32% and 35% lower over 60 days of storage in cartoons 
grapefruit juice. The juice in the cartoon container was made with pulp and stored under 
refrigerated conditions with maximum storage time of 60 days. 
Wangensteen et al proposed that during commercial manufacturing of juice 
epoxybergamottin present in the grapefruit peel possibly distributed into the juice and by 
hydrolysis epoxybergamottin may convert to more potent CYP3A4 inhibitor, DHB (86). 
However, we did not observe the increased levels of furocoumarins in the processed 
juice. Interestingly processed juice contains fewer amounts of DHB and bergamottin than 
hand squeezed juice. This fact is support by the study that, fresh squeezed grapefruit juice 
has been shown to increase the bioavailability of terfanadine by twofold compared to 
commercially processed juice (17). Commercial grapefruit juice is manufactured in a 
multi-step process, which includes washing, puncturing of peel to get essential oils and 
squeezing of the whole fruit to juice. The juice is heated during pasteurization process 
and finally essential oil, an important constituent of grapefruit peel, is added as a flavor 
enhancer to the commercially produced grapefruit juice. 
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Figure 4.9. Effect of γ-irradiation on DHB levels of Rio Red and Marsh White 
grapefruit. 
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Figure 4.10. Effect of γ-irradiation on paradisin A levels of Rio Red and Marsh White 
grapefruit. 
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Figure 4.11. Effect of γ-irradiation on bergamottin levels of Rio Red and Marsh White 
grapefruit. 
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Figure 4.12. Levels of furocoumarins in hand squeezed (HS) juice and commercial 
processed (CP) juice. The results represent mean ± SD for 15 samples. 
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Table 4.1. Influence of temperatures during storage on the levels of furocoumarins in Rio 
Red and Marsh White grapefruits. 
 
Grapefruit 
Cultivars 
Storage 
Temperature Days Levels of Furocoumarins (µg/ml) 
      DHB Paradisin A Bergamottin 
Rio Red 9 ºC 0   1.201 ± 0.061a* 0.09 ± 0.004 a 1.005 ± 0.049 a 
  15 1.137 ± 0.078 a 0.088 ± 0.002 a 0.995 ± 0.062 a 
  30 1.108 ± 0.069 a 0.087 ± 0.004 a 0.978 ± 0.028 a 
  45 1.098 ± 0.068 a 0.076 ± 0.006 b 0.965 ± 0.37 a 
      
 24 ºC  0 1.201 ± 0.061 a 0.09 ± 0.001a 1.005 ± 0.049 a 
  15 1.091 ± 0.055 a 0.077 ± 0.004 b 0.909 ± 0.055 b 
  30 0.998 ± 0.014 b 0.069 ± 0.007 b 0.896 ± 0.081 b 
            
Marsh 
White 9 ºC 0 1.704 ± 0.043 a 0.092 ± 0.004 a 1.437 ± 0.038 a 
  15 1.689 ± 0.076 a 0.089 ± 0.006 a 1.426 ± 0.04 b 
  30 1.618 ± 0.091 b 0.086 ± 0.0052 a 1.408 ± 0.044 c 
  45 1.587 ± 0.068 c 0.085 ± 0.003 a 1.397 ± 0.083 d 
      
 24 ºC  0 1.704 ± 0.043 a 0.092 ± 0.005 a 1.437 ± 0.038 a 
  15 1.593 ± 0.099 d 0.081 ± 0.003 a 1.406 ± 0.019 e 
    30 1.467 ± 0.065 e 0.071 ± 0.002 a 1.396 ± 0.045 f 
 
*Mean ± standard deviation, n=15. 
aMeans with a different letter, differ for the levels of the particular compound in the fruits 
significantly, P < 0.05. 
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Table 4.2. Influence of storage on the levels of furocoumarins in different grapefruit 
juice. 
 
Type of Containers Days Levels of Furocoumarins (µg/ml) 
    DHB Paradisin A Bergamottin 
Cans     
 0 2.065 ± 0.081*a 0.099 ± 0.004 a 1.255 ± 0.028 a 
 15 1.985 ± 0.092 b 0.088 ± 0.003 b 1.223 ± 0.046 b 
 30 1.885 ± 0.015 c 0.078 ± 0.003 c 1.213 ± 0.021 c 
 45 1.772 ± 0.064 d 0.069 ± 0.004 d 1.193 ± 0.037 d 
 60 1.598 ± 0.109 e 0.065 ± 0.015 e 1.166 ± 0.045 e 
 75 1.499 ± 0.089 f 0.061± 0.028 f 1.142 ± 0.013 f 
  90 1.411 ± 0.037 g 0.056 ± 0.007 g 1.1138 ± 0.049g 
Cardboard     
 0 2.125 ± 0.073a 0.104 ± 0.008a 1.487 ± 0.071a 
 15 1.985 ± 0.092a 0.097 ± 0.005b 1.354 ± 0.087b 
 30 1.818 ± 0.108b 0.089 ± 0.001c 1.285 ± 0.051c 
 45 1.789 ± 0.089c 0.076 ± 0.003d 1.116 ± 0.119 d 
 60 1.5612 ± 0.089d  0.074 ± 0.006e 1.099 ± 0.19e 
 75 1.4511 ± 0.061e 0.072 ± 0.002f 1.037 ± 0.017f 
  90 1.4198 ± 0.183f 0.066 ± 0.004g 1.004 ± 0.105g 
Cartons      
 0 2.3146 ± 0.091a 0.1009 ± 0.006a 1.8655 ± 0.091a 
 15 2.1485 ± 0.092b 0.0981 ± 0.013a 1.6813 ± 0.086b 
 30 1.9915 ± 0.105c 0.0883 ± 0.008b 1.4513 ± 0.107c 
 45 1.8212 ± 0.064d 0.0769 ± 0.017c 1.3193 ± 0.045d 
  60 1.7598 ± 0.109e 0.0685 ± 0.009d 1.2168 ± 0.021e 
 
*Mean ± standard deviation, n=15. 
aMeans with a different letter, differ for the levels of the particular compound in the 
containers significantly, P < 0.05. 
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Finally, health benefits of bioactive compounds may not have any practical 
significance if the irradiation, storage and processing makes the fruits/juices 
unmarketable and unacceptable. Citrus fruits are an important source of Vitamin C in the 
human diet. Studies have shown that loss of vitamin C is minimal when citrus fruits were 
exposed to irradiation doses up to 1KGys (113). Our study demonstrates that irradiation 
at 1KGys did not affect the Vitamin C content in Rio Red, but higher doses reduced it 
considerably. Vitamin C degradation can cause browning which leads to the problem of 
quality loss during high dose irradiation. Vitamin C degradation products react with 
amino acids leading to the formation of brown pigments; hydroxymethylfurfurol is one of 
the decomposition products of vitamin C and is a suggested precursor of brown pigments 
(101). It is possible that, high dose of E-beam (10KGys) irradiated grapefruit received the 
lowest acceptability, due to decomposition of some of the bioactive compounds including 
vitamin C. 
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CHAPTER V 
EVALUATION OF GRAPEFRUIT JUICE AND ITS FUROCOUMARINS ON 
CYTOCHROME P450 3A4, 2D6, AND 2C9 ISOENZYMES ACTIVITY AND P-
GLYCOPROTEIN 
Synopsis 
Cytochrome P450 enzyme family is the most abundant and responsible for the 
metabolism of more than 60% of currently marketed drugs and is considered central in 
many clinically important drug interactions. Grapefruit juice increases the bioavailability 
of certain drugs mainly by inhibiting the cytochrome P450 enzymes and modulating the 
activity of transporter proteins. Seven different grapefruit juices and Pummelo juice as 
well as five furocoumarins isolated from grapefruit juice were evaluated at different 
concentrations on CYP3A4, CYP2C9 and CYP2D6 isoenzymes activity. Grapefruit and 
Pummelo juices were found to be potent inhibitors of cytochrome CYP3A4 and CYP2C9 
isoenzymes at 5% concentration while CYP2D6 was scarcely affected. Among the five 
furocoumarins tested, the inhibitory potency was in the order of paradisin 
A>dihydroxybergamottin>bergamottin>bergaptol>geranylcoumarin at a range of 0.1 µM 
to 0.1 mM concentrations.  The IC50 value was lowest for paradisin A for CYP3A4 with 
0.11 µM followed by DHB for CYP2C9 with 1.58 µM.  
 
Introduction 
Cytochrome P450 enzymes are electron-transporting proteins that contain a heme-
prosthetic group in which iron alternates between a reduced (ferrous, Fe2+) and oxidized 
(ferric, Fe3+) state (114). In humans, cytochrome enzymes have been classified into 18 
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gene families with more than 50 enzymes in each and are mostly found on the 
endoplasmic reticulum. Individual isoenzymes are thought to be responsible for the 
metabolism of specific substrates. The cytochrome enzyme family is involved in the 
metabolism and detoxification of environmental carcinogens, drugs, steroids, bile acids, 
fatty acids, eicosanoids, and fat soluble vitamins (115, 116). Certain cytochrome P450 
isoenzymes, such as CYP3A4, CYP1A2, CYP1B1, CYP19, CYP32D6 and CYP32C9, 
have specific roles in the onset of several types of cancers (117-120). Therefore, 
inhibition of cytochrome enzymes by naturally occurring compounds may represent a 
novel approach in the anti-carcinogenesis strategy (116). Exposure to environmental 
chemicals is considered a major risk factor for several types of cancers. These exposures 
can result in the generation of reactive oxygen and nitrogen species such as singlet 
oxygen, super-oxide, nitrogen peroxynitrite and nitrogen dioxide (121), which have been 
implicated as causative agents for many diseases including inflammatory and 
degenerative diseases, arthritis, retinitis pigmentosis, coronary artery diseases, and many 
types of cancers (121). In humans, many of the chemicals are pro-carcinogens and are 
activated to carcinogenic and mutagenic substances by microsomal enzymes (115, 121). 
The human microsomal enzyme system consists of scores of cytochrome P450 
isoenzymes. In vitro studies with certain phytochemicals revealed a reduction in activities 
involved with generation of carcinogens through partial inhibition of these enzymes (122-
124). 
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Cytochrome P450 3A4, 2C9 and 2D6 
 Cytochrome P450 3A4 (CYP3A4) is the most abundant among all the cytochrome 
P450 enzymes. It is expressed in human liver and small intestine and also in some extra-
hepatic tissues such as lungs, stomach, colon and adrenal. In fetal liver, P450 3A7 is the 
most abundant form of CYP3A4 (125). Members of the CYP3A subfamily are the most 
abundant cytochrome enzymes in humans, accounting for 30% of total cytochrome in 
liver and 70% of those in the gut (126).  CYP3A family enzymes are inducible by 
barbiturates, rifampicin, dexamethasone, and others factors. A general correlation was 
shown between enzymes and mRNA levels in human livers; CYP3A4 is probably 
degraded by an ubiquitin linked pathway (125). CYP3A4 contributes to the metabolism 
of approximately 50% of the drugs marketed or under development.  Many of these are 
important drugs such as lovastatin, statins, prostate hypertrophy inhibitor, 
immunosuppressants, protease inhibitors and sildenafil (125). This affects drug 
development process and clinical use related to the role of drug disposition, 
bioavailability and drug interactions such as drug-drug and food-drug interactions. 
CYP3A4 is also involved in the metabolism of cancer chemotherapeutic drugs and 
activation of carcinogens. Elevated enzyme levels reduce the bioavailability and 
variations in the CYP3A4 levels pose clinical challenge, when therapeutic window is 
narrow for a given drug (125).  
 Cytochrome P450 2C9 is primarily a hepatic P450 but also expressed in small 
intestine and the levels of expression is next highest to CYP3A4.  This is one of the major 
enzymes involved in the metabolism of drugs. This enzyme is induced by barbiturates 
and rifampicin and selectively inhibited by sulfaphenazole (125). Cytochrome P450 2D6 
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is the first enzyme recognized in xenobiotics –metabolizing P450 enzyme. This enzyme 
expressed mainly in liver, lung and brain, accounts for approximately 5% of the total 
P450s, wide variation. However this enzyme accounts for oxidation of approximately 
25% of the drugs metabolized by cytochrome P450 enzymes. Available information 
indicates that CYP2D6 is not inducible, rather expressed constitutively (127). Wide 
variability in the activity of CYP2D6 is mainly due to the genetic variability.  
Cytochrome P450 enzymes are the major drug metabolism enzymes and some of 
the main components of phase I metabolism. The cytochrome P450 enzyme system 
transforms lipophilic drugs to more polar compounds that can be excreted in urine (126). 
The metabolites are generally less active than the parent compound, but in some cases the 
metabolites can be toxic, carcinogenic or teratogenic (125). Induction and inhibition 
(125) are the most common causes of altered drug biotransformation during drug-drug 
and food-drug interaction. The effect of limonoids and flavonoids in inducing glutathione 
S-transferase, a major phase II detoxifying enzyme and inhibition of certain CYP 
enzymes activity is well documented (128, 129). Unique bioactive compounds, which 
inhibit CYP enzyme, are furocoumarins from the grapefruit juice, which have been 
interfering with certain drugs by inhibiting CYP3A4 and interfering with transporter 
activity of membrane transporters. Bergamottin, a major component of grapefruit juice 
inhibited the activities of several cytochrome isoenzymes and inactivated CYP3A4 in a 
time- and concentration-dependent manner, via reactive furano-epoxide that covalently 
binds to CYP3A4 (130). 
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P-glycoprotein 
P-glycoprotein is a 170 KDa, membrane-localized efflux protein, which belongs 
to the ATP-binding cassette (ABC) super-family of transporters.  This protein actively 
pumps out xenobiotics, including drugs from intercellular cytoplasm (131), which may 
result in limited bioavailability of drugs. P-glycoprotein appears to be part of a 
mechanism to protect the body from harmful substances. It is the part of first-pass 
metabolism, acting as “gate keeper” for absorption of drugs into the systemic circulation. 
It has been implicated as a primary cause of multi-drug resistance in tumors (132).  
The objective of this study was to evaluate the effect of different grapefruit juices 
and isolated furocoumarins from grapefruit juice on the activity of CYP3A4, 2D6 and 
2C9 isoenzymes and also on P-glycoprotein. 
 
Materials and Methods 
Juices and Furocoumarins. The compounds were isolated from grapefruit juice 
and grapefruit peel oil as described in the previous chapter. The pure compounds and 
grapefruit were used to evaluate the inhibitory effects on CYP3A4, CYP2C9, and 
CYP2D6 enzymes. Rio Red, Ruby Red, Ray Red, Star Ruby, Thompson Pink, Marsh 
White, Duncan and Pummelo grapefruits were collected from Texas A&M University 
Kingsville, Weslaco TX. Fruits were squeezed and juice was centrifuged at 4000 rpm, the 
supernatant was decanted and stored at -80 °C until used. Various concentrations of 
juices starting from 1% to 80% were prepared by diluting in millipore water.  Stock 
solutions (50 mM) of DHB, paradisin A, bergamottin, bergaptol and geranylcoumarin 
were prepared in acetonitrile and kept at 4 °C. Working solutions of 0.01 to 1000 µM 
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solutions were prepared from the stock solution before starting the CYP3A4 inhibition 
assay experiment.  
CYP3A4, CYP2C9, CYP2D6 and Substrates. Membrane preparation 
containing recombinant human CYP3A4, CYP2C9, and CYP2D6 (expressed from cDNA 
using a baculovirus expression system), specific cytochrome enzyme substrates luciferin 
6’ benzyl ether, 6’ deoxyluciferin and ethyl glycol ester of luciferin 6’ methyl ether, assay 
mixtures and luciferin were purchased from Promega (Promega Inc., Madison WI). 
Ketoconazol, sulfaphenazole and quinidine were purchased from Sigma-Aldrich (Sigma-
Aldrich, St. Luis, MO).   
P-glycoprotein and Substrates. Membrane preparation containing recombinant 
human P-glycoprotein, verapamil and sodium orthovanadate, and assay mixtures were 
purchased from Promega (Promega Inc., Madison WI, USA).  
CYP3A4, CYP2C9 and CYP2D6 Inhibition Assay. Inhibition assays were 
performed to evaluate the effect of grapefruit juices and furocoumarins on CYP3A4, 
CYP2C9, and CYP2D6 activity. Inhibition assays were performed as follows, to a 96-
well microtiter plate 12.5 µl of luciferin free water (positive control) or 
ketoconazol/sulfaphenazole/quinidine (positive control for inhibition) and test 
compounds were added to the appropriate wells at 4X concentrations. Thawed, 12.5 µl of 
control reaction mixture and membrane preparations containing CYP3A4/2C9/2D6 were 
added at 4X concentration to the respective wells. The reaction mixture was mixed by 
shaking the plate and plate was pre-incubated at 37 oC for 10 minutes. The 
CYP3A4/2C9/2D6 assay reaction was started by adding 25 µl of 2X NADPH 
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regeneration systems to all the wells. The reaction mixture was mixed by shaking the 
plate and plate was incubated at 37 oC for 30 minutes. After 30 minutes 50 µl of 
reconstituted luciferin detection reagent was added to all wells. Reaction mixture was 
mixed briefly on a plate shaker. The plate was incubated at 37 oC for 20 minutes. The 
luminescence was recorded using a plate-reading luminometer in terms of relative light 
units (RLU). 
P-gp Activity Assay. To determine the effect of grapefruit juices and 
furocoumarins P-gp activity, assay was performed as follows. To a 96 well microtiter 
plate, 20 µl of P-gp-Glo assay buffer/20µl 0f 0.25mM  Na3VO4 in assay buffer/20 µl of 
0.5 mM verapamil in assay buffer/20µl of 2.5X of test compounds were added to 
control/sodium ortho-vanadate/ATP standard/verapamil/test compound wells, 
respectively. To each well, 20 µl of diluted P-gp membranes were added. The mixture 
was mixed by shaking the plate and plate was incubated at 37 oC for 5 minutes. The 
reaction was initiated by adding 10 µl of 25mM MgATP to all wells except those for 
ATP standards. Reaction mixture was mixed briefly on a plate shaker. The plate was 
incubated at 37 oC for 40 minutes. ATP standards of 10 µl were added to appropriate 
wells for ATP standard curve, at the end of 40 minutes incubation. After incubation, the 
reaction was stopped and luminescence was initiated by adding 50 µl of ATP detection 
reagent to all the wells. The reaction mixture was mixed briefly by shaking the plate, then 
the plate was incubated for 20 minutes at room temperature to develop luminescent 
signal. The luminescence was recorded using a plate-reading luminometer interms of 
relative light units (RLU). 
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Statistical Analysis. The inhibition was calculated on the basis of the relative 
activity of the positive control. The positive control was chosen as 100%. The percent 
inhibition was calculated from the formula 100 – [(relative AI activity/relative activity of 
positive control) X 100]. IC50 values were calculated using GraphPad Prism version 4.03 
for Windows, (GraphePad Software, San Diego California, USA).   
 
Results and Discussion 
Inhibition of in vitro CYP3A4/2C9/2D6 Activity by Grapefruit and Pummelo 
Juices. Results of CYP3A4/2C9/2D6 isoenzymes inhibition by Rio Red, Ruby Red, Ray 
Red, Star Ruby, Thompson Pink, Marsh White, Duncan and Pummelo juices at 1%, 5% 
and 25% concentrations are summarized in Figure 5.1 5.2 and 5.3 Differential Inhibition 
of cytochrome isoenzymes was demonstrated by grapefruit juices and Pummelo juice. 
Among the three enzymes, CYP2C9 was inhibited 48.12% by Ray Red and 73.88% by 
Pummelo juice at 1% concentration, while CYP2D6 was inhibited the least with 
maximum inhibition of 12.70% by Pummelo juice. However, maximum inhibition was at 
10% and 25% concentration and observed in the range of 96.69% to 99.88% and 96.51% 
and 100% for CYP3A4 and CYP2C9, respectively. Inhibition of CYP2D6 at 10% was 
comparable with inhibition of CYP3A4 and CYP2C9 at 1%, while CYP2D6 inhibition 
was in the range of 73.20% to 89.99% at 25% of juice. The order of inhibition was found 
to be CYP2C9 > CYP3A4 > CYP2D6 at all the concentrations. 
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Figure 5.1 Inhibition of CYP3A4 activity by grapefruit and Pummelo juices. (1) 
ketoconazol (2) Rio Red grapefruit juice, (3) Ruby Red grapefruit juice, (4) Ray Red 
grapefruit juice, (5) Star Ruby grapefruit juice, (6) Thompson Pink grapefruit juice, (7) 
Marsh White grapefruit juice, (8) Duncan grapefruit juice and (9) Pummelo juices at 1%, 
10% and 25% concentrations. Values are mean ± SD, n = 3.  
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Figure 5.2 Inhibition of CYP2C9 activity by grapefruit and Pummelo juices. (1) 
sulfaphenazole, a known CYP2C9 inhibitor at 10 µM concentration, (2) Rio Red 
grapefruit juice, (3) Ruby Red grapefruit juice, (4) Ray Red grapefruit juice, (5) Star 
Ruby grapefruit juice, (6) Thompson Pink grapefruit juice, (7) Marsh White grapefruit 
juice, (8) Duncan grapefruit juice and (9) Pummelo juices at 1%, 10% and 25% 
concentrations. Values are mean ± SD, n = 3. 
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Figure 5.3 Inhibition of CYP2D6 activity by grapefruit and Pummelo juices. (1) 
quinidine, a known CYP2D6 inhibitor at 1 µM concentration, (2) Rio Red grapefruit 
juice, (3) Ruby Red grapefruit juice, (4) Ray Red grapefruit juice, (5) Star Ruby 
grapefruit juice, (6) Thompson Pink grapefruit juice, (7) Marsh White grapefruit juice, 
(8) Duncan grapefruit juice and (9) Pummelo juices at 1%, 10% and 25% concentrations. 
Values are mean ± SD, n = 3. 
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  Inhibition of CYP3A4/2C9/2D6 Activities by the Isolated Furocoumarins. 
Various furocoumarins such as dihydroxybergamottin, paradisin A, bergamottin, 
bergaptol and geranylcoumarin were isolated from the grapefruit and results of 
CYP3A4/2C9/2D6 isoenzymes inhibition by at various concentrations are summarized in 
Figure 5.4, 5.5 and 5.6. Among the furocoumarins, paradisin A was the potent inhibitor 
of all the isoenzymes, followed by DHB, bergamottin, bergaptol and geranylcoumarin. 
CYP3A4 was inhibited almost completely by paradisin A at 10 µM and inhibition 
potential was more than the positive control ketoconazol, while DHB, bergamottin, 
bergaptol and geranylcoumarin inhibited >96% of activity at 100 µM. IC50 values for all 
three isoenzymes for dihydroxybergamottin, paradisin A, bergamottin, bergaptol and 
geranylcoumarin are presented in Table 5.1. Among all the furocoumarins the lowest 
IC50 was observed for paradisin A against CYP3A4 followed by CYP2C9 and CYP2D6. 
IC50 for bergamottin and geranylcoumarin against CYP2C9 was almost 10 times less than 
that of CYP3A4. The IC50 values for furocoumarins were in the order of geranylcoumarin 
> bergaptol > bergamottin > DHB > paradisin A.  
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Figure 5.4 Inhibition of CYP3A4 activity by furocoumarins. Abbreviations for 
compounds are as follows DHB (Dihydroxybergamottin), PARA (Paradisin A), BERG 
(Bergamottin), BTOL (Bergaptol) and GC (Geranylcoumarin). Values are mean ± SD, 
n=3. 
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Figure 5.5 Inhibition of CYP2C9 activity by furocoumarins. Abbreviations for 
compounds are as follows DHB (Dihydroxybergamottin), PARA (Paradisin A), BERG 
(Bergamottin), BTOL (Bergaptol) and GC (Geranylcoumarin). Values are mean ± SD, 
n=3. 
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Figure 5.6 Inhibition of CYP2D6 activity by furocoumarins. Abbreviations for 
compounds are as follows DHB (Dihydroxybergamottin), PARA (Paradisin A), BERG 
(Bergamottin), BTOL (Bergaptol) and GC (Geranylcoumarin). Values are mean ± SD, 
n=3. 
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Table 5.1 IC50 values of DHB, paradisin A, bergamottin, bergaptol and geranylcoumarin 
for CYP3A4, CYP2C9 and CYP2D6 enzymes. 
 
Compounds CYP3A4 CYP2C9 CYP2D6 
DHB 9.77 1.58 5.63 
Paradisin 0.11 0.18 0.30 
Bergamottin 22.91 4.50 11.74 
Bergaptol 25.82 9.92 37.33 
Geranylcoumarin 53.47 21.51 56.21 
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Effects of Grapefruit Juices and Furocoumarins on P-glycoprotein Activity. 
Effects of grapefruit juices and furocoumarins on P-glycoprotein activity are summarized 
in Table 5.2. Both Rio Red and commercial pink grapefruit juices increased the ATPase 
activity of P-gp in concentration dependent manner at 1% and 5% concentrations. Among 
the two juices, commercial pink grapefruit juice increased the activity of ATPase more 
than fresh Rio Red grapefruit juice. All five furocoumarins increased the ATPase activity 
of P-gp. The highest activity was observed with geranylcoumarin at 10 µM while lowest 
was observed with bergaptol at 1 µM concentration.  
Cytochrome P450 is the single most important drug-metabolizing enzyme family. 
Among the isoenzymes, CYP3A, CYP2D and CYP2C are responsible for metabolism of 
50%, 25% and 20% of drugs metabolized by cytochrome enzyme family, respectively 
(59). Most lipophilic drugs are either metabolized by cytochrome P450 or pumped back 
into gut lumen by the P-glycoprotein transporter (133). Thus, cytochrome P450 and P-
glycoprotein act in tandem as a barrier to the oral delivery of many drugs (134). 
Medications such as cyclosporine, ketoconazole erythromycin, itraconozole and diltizem 
inhibit both intestinal and hepatic CYP3A4 reducing pre-systemic drug metabolism, 
resulting in an increase in the oral bioavailability of the absorbed drug (135-137).  
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Table 5.2 Effect of furocoumarins and grapefruit juice on P-glycoprotein ATPase 
activity.  
 
   
 Compounds 1 µM 10 µM 
DHB 1.331 ± 0.262 1.509 ± 0.195 
Bergamottin 1.242 ± 0.245 1.428 ± 0.134 
Bergaptol 1.098 ± 0.171 1.890 ± 0.308 
Geranylcoumarin 1.338 ± 0.347 2.599 ± 0.254 
Juices 1% 5% 
Rio Red 2.410 ± 0.081 3.628 ± 0.100 
Commercial (Pink juice) 3.334 ± 0.105 4.074 ± 0.133 
Controls/Standards     
Positive control 1.000 ± 0.152  
Varapamil (0.125 mM) 1.735 ± 0.082  
Na3VO4 (0.25 mM)        0 ± 0.190  
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Co-administration of grapefruit juice with drugs including a number of 
dihydropyridine calcium channel blockers, cyclosporine, midazolam, triazolam and 
terfanadine drugs resulted in substantial increase in their oral bioavailability, with 
possible unintended reactions such as headaches, hypotension, facial flushing and 
lightheadedness (138). Grapefruit juice increases the bioavailability of drugs mainly by 
inhibiting the first pass metabolism by cytochrome P450 isoenzymes. Grapefruit juice 
contains several bioactive compounds such as flavonoids, limonoids and coumarins. 
Some of the flavonoid aglycones such as naringenin, apigenin, hesperetin, quercetin and 
kaempferol are reported to inhibit microsomal CYP3A mediated oxidation of drugs in rat 
and human livers (139). Initial investigations considered naringin and its aglycone 
naringenin as possible compounds responsible for drug interactions (140). Nevertheless, 
when naringin was co-administered with felodipine in vivo, it did not show a clear 
influence on the pharmacokinetics of the drug (140). Therefore, the activity of flavonoids 
on CYP3A4 in vivo remains unclear. Grapefruit juice contains several furocoumarins and 
its derivatives which are considered as possible candidates for drug interactions. Several 
furocoumarins have been reported from grapefruit juice with differential inhibitory effect 
on CYP P450 enzymes. Bergamottin and 6’, 7’ –dihydroxybergamottin are the major 
furocoumarins, whereas paradisin A and paradisin B are 100 times stronger inhibitors of 
microsomal CYP3A4 (42). Interestingly, grapefruit juice has no effect on the 
bioavailability of drugs when the drugs are administered intravenously, suggesting the 
involvement of intestinal CYP3A inhibition, not the hepatic CYP 3A inhibition as the 
major cause for increased oral bioavailability (49).  
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Variation in the IC50 values for different compounds and for different isoenzymes 
from this study may be ascribed to the affinity of furocoumarins towards formation of 
enzyme- inhibitor complex. Interestingly, IC50 values for furocoumarins are less than that 
of flavonoids and limonoids (42). It is possible that furocoumarins are more non polar 
than flavonoids and may easily move towards the non-polar membrane environment 
where the majority of cytochrome P450 enzymes and transporter proteins are localized in 
the cells. Structural-functional variations in different furocoumarin molecules may be 
attributed to the differences in efficacy, in inhibiting the different cytochrome isoenzymes 
(141). Bergamottin-induced inactivation led to the loss of up to 50% of CYP3A4 
apoprotein, perhaps via apoprotein modification in the active site of the enzyme. 
Metabolites of bergamottin may undergo oxidation to form a reactive furanoepoxide that 
covalently binds to CYP3A4. Grapefruit juice seems to interact with P-glycoprotein as P-
glycoprotein and CYP3A have overlapping substrate specificities. Soldener and co-
workers discovered that furocoumarins shown to activate P-glycoprotein in intestinal cell 
monolayer in vitro resulting in an increased activity of P-glycoprotein (142).  
Inhibition of cytochrome P450 enzymes by grapefruit juices and its 
furocoumarins offers some clinical advantages in improving bioavailability of poorly 
absorbed drugs, such properties could help reduce the dose requirements and decrease the 
cost and harnessing the health benefits of consuming grapefruit juice. In addition, 
grapefruit juice bioactive components may act as potent inhibitor of cytochrome P450 
enzymes which are involved in the activation pro-carcinogen to carcinogen. This 
represents a unique mechanism in the anti-carcinogenesis strategy, part of which includes 
reducing the generation of reactive oxygen species.  
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CHAPTER VI 
EVALUATION OF GRAPEFRUIT JUICE AND ITS FUROCOUMARINS ON 
AUTO-INDUCER SIGNALING AND BIOFILM FORMATION IN 
PATHOGENIC BACTERIA 
 
Synopsis 
In the present study natural furocoumarins from grapefruit juice were evaluated 
for anti-quorum sensing activity and found the potent inhibition of AI-I and AI-2 
activities at concentrations as low as 0.01%. Grapefruit juices at 5% concentration 
inhibited >99% of AI-1 and AI-2 activities. These results suggest that grapefruit juice can 
serve as a source of alternatives to the halogenated furanones to develop strategies 
targeted at microbial quorum sensing.  
 
Introduction 
The discovery of quorum sensing in bacteria opened another avenue to control 
microbial infections (143). Quorum sensing appears to play a key role in the gene 
expression related to microbial infections and food spoilage (144). In quorum sensing, 
small signaling molecules called auto-inducers (AI) mediate the ability to sense the size 
of a bacterial population (145). Auto-inducers are constantly produced and received at a 
basal level by bacterial cells. Studies have shown that two auto-inducer systems, N-
acylhomoserine lactone (AI-1) and a furanosyl borate diester molecule (AI-2) are 
involved in quorum sensing signaling in Vibrio harveyi (146, 147). These molecules 
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interact with a transcriptional regulator, the LuxR homologues, to activate the expression 
of genes involved in the production of luminescence in Vibrio species (148, 149).   In 
other bacteria, these signaling molecules are also involved in regulation of virulence 
factors (148, 150), antibiotic production and sporulation (151).  
Quorum sensing plays a major role in gene regulation in many environments and 
pathogens rely on these communication systems to promote infection (144). Bacteria use 
auto-inducer molecules to communicate between each other and form structured, sessile 
communities or biofilms (152). Bacterial biofilm formation is a trait closely related to 
pathogenicity (144, 153).  According to NIH report, biofilms associated with over 80% of 
all the microbial infections causing urinary tract infections, catheter infections, biliary 
tract infections, formation of dental plaque, gingivitis and lethal infections such as cystic 
fibrosis (154). These communities develop structures that are morphologically and 
physiologically differentiated from free living bacteria and can survive antibiotic 
treatment and are often responsible for medical treatment failures (155). Recently, there 
has been an increased research work aiming at prevention, control and eradication of 
biofilms (156) and one particular approach is the interruption or inhibition of the bacterial  
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quorum sensing. Several types of synthetic acylhomoserine lactones (AHL) analogues 
have been identified as quorum sensing inhibitors (157). Synthetic halogenated furanones 
have been shown to inhibit bacterial quorum sensing in P. aeruginosa and exhibited 
favorable therapeutic effects on its infection (157). However, halogenated furanone 
compounds are unstable and unsuitable for human use. Identification of naturally 
occurring compounds that interfere with intra- and inter-species cell-to-cell 
communication could provide new treatment strategies to prevent infections (158) and 
can be used as a safe alternative to the halogenated furanones. Furocoumarins and 
synthetic halogenated furanones share common structural “furan” moiety with AI 
signaling molecules (159), which may interfere with the natural AI signaling system 
(Figure 6.1). In the light of the above fact, in the present study we evaluated anti-quorum 
sensing properties of grapefruit juice and its bioactive furocoumarins, and also their 
effects on growth rate and biofilm formation in Escherichia coli, Salmonella 
Typhimurium and Pseudomonas aeruginosa.  
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Figure 6.1. Structure of quorum sensing signal molecules. A) N-acyl homoserine 
lactones where R1 = H, OH, or O and R2 = C1-C18 and synthetic furanone compounds B) 
furanone C30, C) furanone C56, and D) penicillic acid produced by fungi. Adopted from 
(153, 157, 160). 
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Materials and Methods  
Preparation of Grapefruit Juices, Grapefruit Peel Oils and Furocoumarins. Rio 
Red and Marsh White grapefruits were harvested in the month of February 2006 from an 
orchard at the Texas A&M University-Kingsville Citrus Center Weslaco, Texas. Fruits 
were juiced in a home blender and juice was centrifuged at 4000 RPM to separate the 
pulp. The supernatant was stored at -80 ºC until they were used for study. Commercial 
grapefruit juice and grapefruit peel oils were obtained from Texas Citrus Exchange 
Mission, TX. Commercial grapefruit juice was pulp-free, made from concentrate 
grapefruit juice. Dihydroxybergamottin (DHB), paradisin A, bergamottin and bergaptol 
were isolated from grapefruit juice with modifications as described in chapter II.  The 
purified furocoumarins were weighed and dissolved in DMSO to get 10 mg/ml stock 
solution. All the four furocoumarins were used at 0.01% concentration assays. However, 
juices and grapefruit peel oil were used at 1% and 5% concentrations.  
Bacterial Strains and Growth Conditions. Strains of Vibrio harveyi BB120, BB886 
and BB170 were used for bioluminescence assays.  Wild type strain BB120 (AI-1+ and 
AI-2+) was used as a positive control for production of AI-1.  Reporter strains BB886 
(luxP::Tn5) and BB170 (luxN::Tn5) were used for detection of AI-1 and AI-2 
respectively (Surette et al., 1999; Lu et al., 2004).  All these strains were kindly provided 
by B. Bassler (Princeton University, Princeton, NJ) and were grown at 30 ºC in 
autoinducer bioassay (AB) medium prepared as described previously (Federle and 
Bassler, 2003).  A solution consisting of NaCl (17.5 g/liter; Sigma, St. Luis, MO), 
MgSO4 (12.3 g/liter; Fisher Chemicals, Fisher Scientific, Fair Lawn, NJ), and casamino 
acids (2 g/liter; Fisher Chemicals) was adjusted to pH 7.5 and sterilized by autoclaving.  
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When the solution had cooled, autoclave–sterilized 1.0 M potassium phosphate (pH 7.0, 
10 ml/liter; Sigma), 50% glycerol (20 ml/liter; EM Science, Gibbstown, NJ) and filter 
sterilized 0.1 M L-arginine (10 ml/liter; Sigma) were added. The environmental isolate E. 
coli #5, used as positive control for production of AI-2 bioassay was grown at 37ºC on 
Luria-Bertani (LB) - Miller broth (Difco Laboratories, Detroit, MI) supplemented with 
0.5% glucose (161). 
Preparation of Cell Free Supernatant (CFS) for AI-1 and AI-2 Assays. To 
prepare cell free supernatant containing high levels of AI-1,  an aliquot (100 µl) of an 
overnight  culture of V. harveyi BB120 was inoculated into 10 ml of fresh AB medium 
and incubated with shaking at 30ºC for 16 hours. To prepare cell free supernatant 
containing high levels of AI-2, an aliquot (100 µl) of an overnight culture of E. coli #5 
(strain known to produce AI-2 molecules) (161)  was inoculated into 10 ml of fresh LB 
supplemented with 0.5% glucose medium and incubated with shaking at 30ºC for 16 
hours. The CFS was prepared by centrifuging (3300× g for 30 min at 4°C) the culture 
followed  by filtration of the supernatant through 0.2 µm-pore size syringe filters (VWR, 
West Chester, PA). The CFS was stored at –20°C until AI-1 and AI-2 bioluminescence 
assays were performed. 
Bioluminescence Assay for AI-1 and IA-2. To determine the effect of 
furocoumarins, grapefruit juices and grapefruit peel oil on AI-1 and AI-2 activity, 
bioluminescence assays were performed as described previously (161). An overnight 
culture of V. harveyi BB886/BB170 was diluted with fresh AB medium (1:5,000) and 90 
µl were added to each well of a 96 well microtiter plate (Perkin-Elmer –Wallac, Boston, 
MA).  To test the inhibition of AI-1/AI-2 activity, 5 µl of V. harveyi BB120/E. coli #5 
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CFS was mixed with 4 µl of AB medium plus 1 µl of the different compounds dissolved 
in DMSO.  This mixture was added to the wells containing 90 µl of the diluted (1:5,000) 
V. harveyi BB886/BB170 culture. The positive control consisted of 90 µl of diluted V. 
harveyi BB886/BB170 culture and 5 µl of V. harveyi BB120/E. coli #5 CFS mixed with 5 
µl of AB media. To test if DMSO has any effect on the reporter strain, control wells were 
prepared with 90 µl of diluted V. harveyi culture, 5 µl of CFS (BB120/E. coli #5) and 4 
µl of AB media with 1 µl DMSO.  The negative control consisted of 90 µl of diluted V. 
harveyi BB886/BB170 culture and 9 µl of AB medium with 1 µl DMSO. The plate was 
shake-incubated (100 rpm) at 30 °C in a Lab-Line Orbital Shaker Incubator (Melrose 
Park, IL) for 4 hours; afterwards luminescence readings were recorded for every 20 
minutes using Wallac Victor 2 luminomter (Perkin Elmer, Boston, MA). The readings 
were taken until the relative light units in the negative control wells reached 
approximately 100 light units.  
Effect of Furocoumarins, Grapefruit Juice and Grapefruit Peel Oil on Biofilm 
Formation of E. coli O157:H7, S. Typhimurium and P. aeruginosa. Overnight cultures 
were diluted in CFA (colonization factor antigen) media at 1:25 proportion. Diluted 
culture of 190/198 µl were added to polystyrene 96-well plates, DHB, bergamottin, 
bergaptol and geranylcoumarin and Rio Red, Marsh White, commercial pink grapefruit 
juices and grapefruit peel oil were added to respective wells of plates, the plates were 
incubated at 37 °C for 24 hours. The appropriate amount of DMSO was added to all 
control wells to find effect of DMSO. To quantify the total biofilm mass, the suspension 
cultures were decanted, the plates were washed with phosphate buffer (pH 7.4), and the 
biofilms were stained with 0.3% crystal violet (Fisher, Hanover Park, IL) for 15 min. The 
  
101
excess dye was removed by washing with phosphate buffer (pH 7.4). Dye associated with 
the attached biofilm was dissolved with 200 µl of 33% acetic acid. The OD was measured 
at 620 nm quantify the total biofilm mass. Each data point was averaged from six 
replicate wells and the standard deviations were calculated.  
Data Analysis. The AI-1 and AI-2 activities were expressed as relative light units 
(RLU). The inhibition was calculated on the basis of the relative activity of the positive 
control. The positive control was chosen as 100%. The percent inhibition was calculated 
from the formula 100 – [(relative AI activity/relative activity of positive control) X 100] 
(161). 
 
Results and Discussion 
Inhibition of AI-1 and AI-2 Activity in V. harvey by Furocoumarins and 
Grapefruit Juice. The percent inhibition of AI-1 activity by various furocoumarins and 
grapefruit juices is shown in Figure 6.2. Among the furocoumarins, maximum inhibition 
was observed with bergaptol (99.15%) and minimum was seen with geranylcoumarin 
(80.88%), while the other two furocoumarins showed >96% of inhibition. Rio Red, 
Marsh White and commercial grapefruit juices showed 47%, 62% and 94% of inhibition, 
respectively at 1% concentration. However, all three juices showed >99% of inhibition 
activity at 5% concentration. It is evident from the results that DHB, bergamottin and 
bergaptol are potent inhibitors of AI-1 activity at 0.01% concentration, while grapefruit 
juice was most effective at 5% in inhibiting AI-1 activity. The percent inhibition of AI-2 
activity by various furocoumarins and grapefruit juice is presented in Figure 3. The 
maximum and minimum inhibition activity was shown by bergaptol (98.85%) and  
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Figure 6.2. Inhibition of AI-1 activity by various furocoumarins, grapefruit juices and 
grapefruit peel oil. DHB, dihydroxybergamottin; BM, bergamottin; BL, bergaptol; GC, 
geranylcoumarin; RR-1, Rio Red grapefruit juice at 1%; MW-1, Marsh White grapefruit 
juice at 1%; PA-1, commercial pink grapefruit juice at 1%; RR-5, Rio Red grapefruit 
juice at 5%; MW-5, Marsh White grapefruit juice at 5%; PA-5, commercial pink 
grapefruit juice at 5% concentrations. Bars in the panel indicate ±SD, n=3. 
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Figure 6.3. Inhibition of AI -2 activities by various furocoumarins, grapefruit juices and 
grapefruit peel oil. DHB, dihydroxybergamottin; BM, bergamottin; BL, bergaptol; GC, 
geranylcoumarin; RR-1, Rio Red grapefruit juice at 1%; MW-1, Marsh White grapefruit 
juice at 1%; PA-1, commercial pink grapefruit juice at 1%; RR-5, Rio Red grapefruit 
juice at 5%; MW-5, Marsh White grapefruit juice at 5%; PA-5, commercial pink 
grapefruit juice at 5% concentrations. Bars in the panel indicate ±SD, n=3. 
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geranylcoumarin (66.01%), respectively. Rio Red and Marsh White grapefruit juices 
showed 16.82% and 27.52% inhibition, respectively at 1% concentration. However, 
commercial grapefruit juice at 1% concentration showed 79.80% inhibition. All three 
grapefruit juices inhibited AI-2 activity by >99% at 5% concentration.  
Effect of Furocoumarins, Grapefruit Juice and Citrus Oil on Biofilm 
Formation of E. coli O157:H7, S. Typhimurium and P. aeruginosa. Results of 
grapefruit juice and furocoumarins effect on biofilm formation are summarized in Table 
6.1. Among the furocoumarins studied, DHB inhibits the biofilm formation by 27.32% 
and 25.75% in P. aeruginosa and E. coli, while geranylcoumarin showed 19.5% 
inhibition in S. Typhimurium. Bergaptol showed 32.65% of inhibition in P. aeruginosa, 
this is the highest among the furocoumarins at 0.01% concentration. All the grapefruit 
juices at 5% concentration were more effective than 1% in inhibiting the biofilm 
formation. Rio Red, Marsh White and pink commercial grapefruit juices showed 42.59%, 
68.09% and 88.9% inhibition of biofilm formation in E. coli, S. Typhimurium and P. 
aeruginosa at 5% concentration.   
Several studies involving plant extracts have demonstrated the anti-quorum 
sensing activity. Vanilla extract (162), garlic extract (163) and several medicinal plants 
extracts from have shown potent anti-quorum sensing activity (143). However, these 
studies lack the active agent of the plant extract responsible for the reported anti-quorum 
sensing activity. In our study, naturally occurring furocoumarins (DHB, bergamottin and 
bergaptol) extracted from grapefruit juice showed almost complete inhibition in both AI-
1 and AI-2 activity at 0.01% concentration. 
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Table 6.1. Percent inhibition of biofilm formation in E. coli O157:H7, Salmonella 
Typhimurium and Pseudomonas aeruginosa by furocoumarins and grapefruit juices.  
 
Furocoumarins 
/Grapefruit juices E. coli S. Typhimurium P. aeroginosa 
DHB 25.75 ± 0.05a 4.90 ± 0.04 27.32± 0.07 
BM 22.70 ± 0.04 6.01 ± 0.13 27.37 ± 0.09 
BL 14.83 ± 0.02 8.04 ± 0.04 32.65 ± 0.08 
GC 10.30 ± 0.03 19.52 ± 0.04 9.24 ± 0.05 
RR-1% 30.94 ± 0.02 9.69 ± 0.06 11.97 ± 0.04 
MW-1% 33.51 ± 0.02 8.91 ± 0.04 18.16 ± 0.02 
PA-1% 32.85 ± 0.04 34.85 ± 0.05 26.44 ± 0.05 
RR-5% 41.65 ± 0.07 43.99 ± 0.07 41.36 ± 0.08 
MW-5% 42.70 ± 0.02 47.55 ± 0.05 44.90 ± 0.07 
PA-5% 42.59 ± 0.06 88.99 ± 0.02 68.09 ± 0.03 
 
DHB; dihydroxybergamottin, BM; bergamottin, BL; bergaptol, GC; geranylcoumarin, 
RR-1; Rio Red grapefruit juice at 1%, MW-1; Marsh White grapefruit juice at 1%, PA-1; 
commercial pink grapefruit juice at 1%, RR-5; Rio Red grapefruit juice at 5%, MW-5; 
Marsh White grapefruit juice at 5%, PA-5; commercial pink grapefruit juice at 5% 
concentrations. Data are presented as mean ± SD of absorbance at 620 nm. 
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The structural resemblance between these furocumarins, the auto-inducer molecules and 
all synthetic halogenated furanones is the furan moiety. Geranylcoumarin, which lacks 
the furan ring in its molecule, showed minimum inhibition of AI-1 and AI-2 activities. 
Natural and isolated furanones have shown to interference with quorum sensing systems 
in V. fischeri, V. harveyi, Serratia liquefaciens, S. ficaria and P. aeruginosa (153).  
It has been reported that halogenated furanones from the marine red alga Delisea 
pulchra are strong inhibitors of the bioluminescence labeled AHL-regulated system in E. 
coli (164). Halogenated furanones have shown inhibitory activity in cultivar of assays 
intended to measure AHL-regulated gene expression and such inhibition was found to be 
partially relieved by increasing AHL concentrations in the bioassays (165). This suggests 
the competition between the AHL-signaling molecules and furanones for a common 
binding site on LuxR and LuxR homologues (164). AHLs are highly conserved and have 
the same homoserine lactone moiety with different cayl side chains and substitutions of 
carboxyl or hydroxyl group at the C3 position (166). AHLs are co-regulatory ligands 
required for control of the expression of genes encoding virulence traits in many Gram-
negative bacteria. The fact that bergaptol, bergamottin and DHB showed strong inhibition 
of quorum sensing without interfering with critical life process makes these quorum 
sensing inhibitors  suitable candidates for treating microbial infections using a non-
antibiotic based strategy,  since the selective pressure for development of bacterial 
resistance could be avoided (148, 157). 
Food-borne illnesses resulting from food poisoning with pathogenic bacteria has been 
of vital concern to public. The recent outbreak of E. coli (August 2006) in spinach is 
vivid example. To reduce health hazards and economic losses due to food borne microbe, 
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the use of plant derived compounds as antimicrobial agents seem to be an interesting way 
to control the pathogenic microbial activity in the food system and extend the shelf life of 
food.  
Plants have long been a source of drugs and continue to contribute to the process of 
drug discovery. Natural products such as alkaloids, phenols, polyphenols, saponins, 
tannins, terpenes, antraquinones and steroids are known to posses antimicrobial activity 
(167). Essential oils are odorous, volatile products of an aromatic compounds produced 
during secondary metabolism. These are normally formed in special cells found in bark, 
stem, leaves, fruit and fruit peel as in case of citrus. Essential oils and their components 
are known to be active against a wide cultivar of bacteria (167).  
Biofilm formation has been shown to cause severe health problems. Biofilms 
constitute a protected mode of growth that allows survival of pathogens in hostile 
environments. Bacterial biofilms growing in natural and industrial environments are 
resistant to bacteriophages, amoeba and diverse antibiotics used against them. Medically, 
biofilms can withstand host immune responses, and they are much less susceptible to 
antibiotics than non-attached individual microbial counterparts. There is tremendous 
interest in naturally-occurring compounds as biofilm controlling and preventing agents. 
Recently ursolic acid was reported as potent inhibitor of biofilm formation in E. coli and 
natural furanones isolated from D. pulchra have been found to reduce biofilm formation 
in E. coli and in B. subtilis (168, 169). 
The results of this study have revealed that furocoumarins and grapefruit juice act as 
potent inhibitors of AI-1 and AI-2 activity. Furocoumarins from the grapefruit juice 
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offers safe alternative to the halogenated furanones to develop anti-quorum sensing 
strategies that might reduce bacterial infections. 
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CHAPTER VII 
EVALUATION OF ANTI-PROLIFERATIVE ACTIVITIES OF 
FUROCOUMARIN MONOMERS AND DIMER ON CANCER AND NORMAL 
CELL LINES 
 
Synopsis 
Furocoumarins have shown spectrum of biological activities such as cytochrome 
P450 enzyme inhibition, modulation of P-glycoprotein activity, anti-quorum sensing and 
anti-oxidant activity. In this study, synthesized furocoumarin monomers and dimer were 
investigated for the anti-proliferative activities on normal and cancer cell lines. 
Compounds were found to be non-toxic to normal cells, as seen in case of NIH-3T3 cells. 
However, bergamottin showed a significant anti-proliferative activity in both HT-29 and 
MCF-7 adenocarcinoma cell lines. 
 
Introduction 
 
Furocoumarins are currently of great interest and research into these bioactive 
compounds is becoming increasingly intense due to their involvement in grapefruit-drug 
interaction. In humans, many of the chemicals are pro-carcinogens and are activated to 
carcinogenic and mutagenic substances by microsomal enzymes (115, 121). Some of the 
important cytochrome P450 isoenzymes are CYP3A4, CYP1A2, CYP1B1, CYP19, 2D6 
and 2C9, which have specific roles in the onset of several types of cancers (115, 117-
120). In vitro studies with certain phytochemicals revealed reduction in carcinogens 
through partial inhibition of these enzymes (112, 124). Thus, inhibition of cytochrome 
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enzymes by naturally occurring compounds may represent a novel approach in the anti-
carcinogenesis strategy (116). The aim of the present work was to evaluate series of 
synthesized furocoumarin monomers and dimer on biological activity against normal and 
cancer cell lines in vitro. 
 
Materials and Methods 
Chemicals. All the chemicals were molecular biology and analytical grade were 
purchased from Sigma-Aldrich, VWR International (1310 Goshen Parkway, West 
Chester, PA). 
Furocoumarin Monomers and Dimer. Compounds were synthesized from 
bergapten as described in chapter II. Stock solutions (10 mM) of bergapten, bergaptol, 
bergamottin, epoxybergamottin, DHB and dimer, paradisin A were prepared in DMSO 
and kept at 4 °C. Working solution of 0.625 to 100 µM solutions were prepared from the 
stock solution before starting the experiment.  
Cell Culture. NIH 3T3, HT-29 and MCF-7 were purchased from the American 
Type Culture Collection (Bethesda, MD) and cultured in DMEM medium supplemented 
with 10% (v/v) fetal bovine serum from Hyclone  (925 West 1800 South Logan, UT).  
Cells were grown on 25 cm2 falcon culture flasks at 37 oC in 5% CO2.  When cells 
reached 70-80% confluence they were detached with Trypsin- EDTA solution and 
quantified using Z1 coulter counter (Beckman coulter Inc, 4300 N. Harbor Boulevard 
Fullerton, CA).   
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Measurement of Cell Viability  
A. MTT Assay. Cell proliferation was evaluated using MTT reagent (3[4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium) assay, which measured the mitochondrial 
dehydrogenase activity of viable cells spectrophotometrically. Cells were seeded at a 
density of 5x104 cells/well  and allowed to attach for 24 hrs, these attached cells were 
treated with furocoumarins dissolved in DMSO  at 6.25, 12.5, 25, 50 and 100 µM in a 96 
-well cell culture plates and were incubated at 37 ºC in 5% CO2 . After 24, 48 and 72 hrs, 
MTT was added to each well. After incubation for 4 h at 37 ºC, medium was removed 
carefully and the intracellular formazan was dissolved by adding 200 µl of DMSO to 
each well. After jolted by the shaker for 5 minutes, the upper solution was transferred to 
another 96-well plate. The absorbance was measured spectrophotometrically at 515 and 
550 nm in microplate reader (KC4, v3.3 microplate reader). Samples were treated in 
triplicates and results were expressed as mean ±SD. 
B. Cell Proliferation Assay by Coulter Counter. MCF-7 Cells were seeded at a 
density of 5x104/well in 12-well plates, and after 24 hours they were treated with media 
mixed with known concentration of samples. Treatment was done at 25, 50 and 100 µM  
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concentration, DMSO at 100µM was used as control treatment and Campothecin at 25 
µM was used as positive control. Cells were counted at 24 and 48 Hrs using a Coulter Z1 
cell counter after detaching using Trypsin-EDTA. Each experiment was completed in 
triplicate and results are expressed as mean ± SD for each determination. 
Assessment of Cytotoxicity by LDH Assay. Cytotoxity was assessed as lactate 
dehydrogenase (LDH) released into the media relative to cultures lysed with 1% Triton 
X-100. This end point was chosen since it coincide with membrane disruption, a late 
stage irreversible step in cytolethality (170). MCF-7 cells were treated with 
furocoumarins at the dose of 25, 50 and 100 µM and the medium was subjected for assay 
after centrifugation to remove cells. Cells were allowed to attach for 24 h and then treated 
in triplicate with varying concentrations of furocoumarins. LHD was estimated using 
Roche (Hoffmann-La Roche Nutley, NJ) cytotoxicity detection kit and calculations were 
done as per instruction in kit using positive and negative control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
113
 
 
 
 
 
 
Table 7.1. Effect of furocoumarin monomers and dimer on the activity on COS7 cell 
lines. Data are expressed as mean ± SD, % of control. 
 
      24 hrs      
Concentration 
(µM) 
5 10 25 50 75 100 
Campothecin 97 ± 2.7 97 ± 0.2 95 ± 2.2 90 ± 2.8 86 ± 0.84 80 ± 1.8 
Bergapten 98 ± 4.3 98 ± 2.2 96 ± 2.0 98 ± 3.1 87 ± 1.4 80 ± 0.5 
Bergaptol 97 ± 3.3 99 ± 1.0 103 ± 5.8 103 ± 6.1 103 ± 1.4 107 ± 3.2 
Bergamottin 102 ± 4.0 107 ± 1.7 115 ± 3.9 125 ± 0.7 125 ± 4.1 129 ± 5.4 
Epoxy-
bergamottin 
100 ± 0.8 100 ± 2.8 104 ± 2.9 112 ± 3.0 126 ± 4.0 132 ± 2.5 
DHB 101 ± 7.9 104 ± 6.7 101 ± 4.9 108 ± 5.0 118 ± 6.5 127 ± 15.1 
Paradisin A 111 ± 3.3 106 ± 9.7 98 ± 3.8 103 ± 1.7 106 ± 6.7 104 ± 2.9 
      48 hrs       
Campothecin 83 ± 0.9 78 ± 2.1 76 ± 6.0 77 ± 2.4 80 ± 3.3 73 ± 1.2 
Bergapten 100 ± 1.9 95 ± 0.7 95 ± 4.1 96 ± 3.9 83 ± 2.1 76 ± 4.7 
Bergaptol 95 ± 1.4 96 ± 4.8 95 ± 4.4 97 ± 6.1 101 ± 0.5 104 ± 5.9 
Bergamottin 100 ± 4.5 96 ± 5.6 95 ± 5.0 89 ± 5.6 80 ± 1.7 73 ± 5.9 
Epoxy- 
bergamottin 
99 ± 0.8 99 ± 1.3 97 ± 2.3 98 ± 3.2 104 ± 2.2 98 ± 3.1 
DHB 105 ± 2.1 103 ± 2.2 102 ± 3.8 104 ± 4.3 110 ± 4.3 117 ± 5.8 
Paradisin A 106 ± 2.1 87 ± 3.2 81 ± 1.5 87 ± 0.9 82 ± 0.8 86 ± 1.0 
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Results and Discussion  
 
Furocoumarin monomers such as bergapten, bergaptol, bergamottin, 
epoxybergamottin, DHB and dimer, paradisin A were evaluated for their effect on normal 
and cancer cell lines. Results indicate that normal COS-7 cells were not affected by any 
of the furocoumarins, as seen by MTT assay results at 24 hrs and 48 hrs (Table 7.1). 
Anti-proliferative activity of all the compounds was less significant on colon 
adenocarcinoma cells (HT 29) at 24 hrs; however bergamottin exhibited activity of 35.74 
% at 100 µM concentration at 48 hrs (Table 7.2). Other compounds did not show 
significant activity. All furocoumarin monomers and dimer showed similar results in case 
of MCF-7 cell lines as measured by MTT assay (Table 7.3). Bergamottin showed ~30% 
inhibition activity at 100 µM concentration followed by epoxybergamottin. However, 
activities of other compounds were not significant.    
All the monomers and dimer when screened for antiproliferation ability on MCF-
7 cells, bergamottin showed more than 50% inhibition activity at the dose of 25, 50 and 
100 µM at 48 hours, followed by paradisin A and DHB However, other compounds 
exhibited moderate activity which was not significant in comparison with campothecin 
(Table 7.4). Furthermore, antiproliferative results were supported by LDH based 
cytotoxicity assay (Table 7.5). Compounds which showed significant antiproliferation 
activity had higher amount of LHD leakage into media, indicating cytotoxicity of the 
compounds in vitro.  
Furocoumarin are widely dispersed in nature and are secondary metabolites in a 
cultivar of plant belonging to such as Umbellifera and Rutacea families (38). Extracts of 
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plants containing furocoumarins such as Psoralea corylifolia and Ammi majus, were used 
in India and Egypt, respectively, as early as 2000 BC to treat hyperproliferative skin 
diseases (171). Furocoumarins have been extensively used in phototherapy coupled with 
ultraviolet light. Psoralen is employed in the treatment of different hyperactive skin 
conditions including vitilago, psoriasis and atopic dermatitis (171). The main mechanism 
of furocoumarin action is based on ability to form photo-adducts with genetic material, 
DNA in some instances RNA, proteins and membrane components (171, 172).  The 
ability of these compound to form adduct, thereby suppressing the replication of genetic 
material would be the main reason for furocoumarins therapeutic activity. Our results 
indicate that there are potential use of bergamottin and other derivatives as inhibitors of 
carcinoma cells. Modification of monomers/dimers by chemical means would enhance 
the activity of these compounds. Further research into these compounds towards 
understanding the mechanism of action and dose optimization may lead to better 
understanding of these molecules as anticancer agents. 
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Table 7.2. Effect of furocoumarin monomers and dimer on the activity on HT-29 cell 
lines. Data are expressed as mean ± SD, % of control. 
 
      24 hrs      
Concentration 
(µM) 5 10 25 50 75 100 
Campothecin 63 ± 2.5 60 ± 1.1 57 ± 3.2 56 ± 1.9 55 ± 1.4 45 ± 10.4 
Bergapten 113 ± 10.0 120 ± 12.9 119 ± 12.4 122 ± 10.0 119 ± 11.1 105 ± 11.8
Bergaptol 104 ± 13.2 113 ± 19.0 115 ± 12.8 113 ± 14.2 119 ± 16.9 122 ± 18.6
Bergamottin 110 ± 9.2 111 ± 7.2 117 ± 6.7 109 ± 6.7 109 ± 4.4 106 ± 2.6 
Epoxy- 
bergamottin 113 ± 1.2 105 ± 2.6 114 ± 7.9 123 ± 2.5 131 ± 0.9 132 ± 1.1 
DHB 117 ± 8.6 120 ± 8.7 129 ± 10.8 130 ± 9.8 129 ± 6.8 116 ± 6.8 
Paradisin A 121 ± 4.2 124 ± 7.3 123 ± 5.7 123 ± 2.4 122 ± 2.2 118 ± 5.4 
      48 hrs       
Campothecin 45 ± 0.8 46 ± 2.8 46 ± 0.2 45 ± 0.7 45 ± 0.9 42 ± 1.6 
Bergapten 117 ± 4.7 112 ± 3.0 104 ± 28.8 113 ± 4.5 104 ± 2.2 91 ± 2.6 
Bergaptol 112 ± 3.0 110 ± 1.9 111 ± 3.5 111 ± 5.8 110 ± 2.0 102 ± 7.5 
Bergamottin 115 ± 8.7 111 ± 6.9 102 ± 1.3 86 ± 4.6 71 ± 4.4 64 ± 1.2 
Epoxy- 
bergamottin 114 ± 5.5 112 ± 3.8 108 ± 3.0 107 ± 1.7 104 ± 12.6 83 ± 0.2 
DHB 128 ± 7.0 118 ± 3.7 126 ± 15.1 120 ± 4.4 127 ± 28.9 93.00 
Paradisin A 116 ± 7.5 113 ± 4.3 107 ± 7.3 111 ± 5.6 97 ± 19.5 100 ± 3.3 
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Table 7.3. Effect of furocoumarins monomers and dimer on the activity on MCF-7 cell 
lines. Data are expressed as mean ± SD, % of control. 
 
 
        24 hrs         
Concentration 
(µM) 0.625 1.25 2.5 5 10 25 50 100 
Bergapten 97.95 98.82 96.22 96.62 95.77 97.77 97.05 77.35 
SD 4.14 4.86 3.04 4.43 4.74 1.03 1.69 3.82 
Bergaptol 95.04 87.24 92.19 87.86 89.12 89.47 85.60 87.62 
SD 1.46 2.96 7.08 1.25 0.32 0.66 1.06 3.28 
Bergamottin 97.41 95.42 97.55 106.84 105.37 116.85 109.46 108.38
SD 1.04 0.03 0.33 4.98 1.82 2.90 9.02 1.74 
Epoxybergamottin 96.18 89.53 89.38 89.51 91.84 97.96 109.38 111.49
SD 1.39 0.37 3.47 4.02 0.84 3.05 5.41 5.89 
DHB 101.55 98.74 98.13 99.43 98.61 97.97 100.81 101.24
SD 0.92 0.02 4.71 0.64 1.96 2.55 1.79  
Paradisin A 109.48 107.38 106.76 113.44 113.24 127.20 128.63 129.83
SD 3.91 4.71 4.33 7.87 4.00 7.53 10.20 15.18 
        48 hrs         
Bergapten 96.99 96.29 93.27 93.22 93.02 94.97 95.22 78.44 
SD 3.00 0.95 0.15 1.72 1.09 0.22 1.02 1.85 
Bergaptol 96.18 91.76 88.48 88.09 86.66 88.51 89.81 93.08 
SD 7.17 4.80 8.39 10.17 8.15 5.01 8.26 6.98 
Bergamottin 86.62 86.55 82.68 86.22 85.94 79.25 75.01 71.96 
SD 6.71 3.69 1.28 2.11 0.88 1.33 0.74 4.10 
Epoxybergamottin 87.51 89.75 93.30 89.97 89.84 89.68 82.73 85.91 
SD 5.13 2.10 1.63 6.04 4.81 6.98 12.41 6.63 
DHB 96.61 93.31 94.97 97.78 100.18 98.25 103.63 100.92
SD 4.80 1.34 1.02 7.98 7.87 11.38 9.71 11.04 
Paradisin A 114.98 102.42 92.03 98.38 96.37 100.84 96.47 106.64
SD 15.32 7.17 0.30 1.31 6.59 4.35 2.38 9.84 
 
 
 
 
 
  
118
 
 
 
 
 
 
 
 
Table. 7.4. Effect of furocoumarin monomers and dimer on proliferation of MCF-7 cells. 
 
 
Treatment 
Conc. In 
µM Cell number x 1000 
    24 hrs 48 hrs 
DMSO 100 16.2 ± 4.96 a 38.7 ± 4.49 
Campothecin 50 8.4 ± 3.05 11.3 ± 7.17 
Bergapten 25 13.7 ± 3.81 26.5 ± 5.08 
 50 12.6 ± 3.31 32.9 ± 5.69 
  100 18.7 ± 1.94 8.8 ± 2.09  
Bergaptol 25 16.65 ± 1.63 51.25 ± 12.64 
 50 20.6 ± 7.84 49.6 ± 9.67 
  100 12.3 ± 1.51 33.3 ± 3.80 
Bergamottin  25 14.9 ± 1.21 13.00 ± 0.83 
 50 13.3 ± 2.31 6.6 ± 2.18 
  100 10.2 ± 2.92 7.00 ± 0.99 
DHB 25 21.8 ± 1.80 22.0 ± 3.08 
 50 10.45 ± 2.03 19.25 ± 4.13 
  100 9.2 ± 1.57 16.1 ± 3.17 
Epoxybergamottin 25 19.9 ± 2.13 25.85 ± 3.26 
 50 13.4 ± 2.00 28.6 ± 5.59 
  100 13.3 ± 5.49 27.5 ± 4.41 
Paradisin A 25 11.3 ± 1.52 22.8 ± 1.02 
 50 10.6 ± 2.5 18.62 ± 0.95 
  100 10.0 ± 0.86 14.4 ± 1.25 
 
aValues are mean of six readings ± SD  
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Table 7.5.  Cytotoxicity of furocoumarin monomers and dimer by LDH assay. 
 
 
Treatment Conc. (µM) % LDH leakage 
    24 hrs 48 hrs 
DMSO 100 49.86 ± 0.08 a 98.19 ± 0.04 
Campothecin 50 59.95 ± 0.12 57.36 ± 0.04 
Bergapten 25 64.11 ± 0.09 55.71 ± 0.19 
 50 80.29 ± 0.08 49.34 ± 0.01 
  100 70.35 ± 0.05 61.34 ± 0.12 
Bergaptol 25 70.35 ± 0.10 58.00 ± 0.12 
 50 62.03 ± 0.07 47.84 ± 0.15 
  100 58.03 ± 0.09 42.63 ± 0.03 
Bergamottin  25 59.03 ± 0.07 57.18 ± 0.13 
 50 73.69 ± 0.03 48.63 ± 0.03 
  100 58.15 ± 0.5 45.81 ± 0.05 
DHB 25 69.25 ± 0.09 49.58 ± 0.17 
 50 61.82 ± 0.10 39.78 ± 0.04 
  100 60.78 ± 0.03 50.47 ± 0.11 
Epoxybergamottin 25 58.03 ± 0.09 51.33 ± 0.13 
 50 50.93 ± 0.04 44.98 ± 0.05 
  100 51.23 ± 0.11 37.74 ± 0.06 
Paradisin A 25 61.10 ± 0.09 32.30 ± 0.15 
 50 51.90 ± 0.11 33.8 ± 0.08 
  100 80.55 ± 0.16 37.6 ± 0.17 
 
aValues are mean of six readings 
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CHAPTER VIII 
SUMMARY AND CONCLUSION 
 
 Grapefruit is considered a “store house” of health-promoting compounds, such as 
carotenoids, limonoids, flavonoids, pectin and vitamin C. Grapefruit juice carries the 
American Heart Association’s “heart check” food mark. However, consumption of 
grapefruit along with a certain medications is posing a risk of drug toxicity and side 
reactions. Furocoumarins are the main components of grapefruit juice, interacting with 
cytochrome P450 enzymes and P-glycoprotein.  
 An efficient and improved technique has been developed for isolation and 
purification of furocoumarins using a combination of chromatographic techniques. Five 
furocoumarins namely, Dihydroxybergamottin, paradisin A, bergamottin, bergaptol and 
geranylcoumarin were isolated from grapefruit and series of furocoumarin monomers and 
paradisin A were synthesized. These compounds were influenced by various pre- and 
post-harvest factors. Variation of three furocoumarins such as dihydroxybergamottin, 
paradisin A and bergamottin were monitored in seven cultivars of grapefruits and its 
parent Pummelo. Considerable differences were observed in the levels of these 
compounds in different grapefruit cultivars. Ray Red showed the lowest (0.492 ± 0.027 
DHB µg/ml, 0.059 ± 0.001 µg/ml paradisin A and 0.344 ± 0.030 µg/ml bergamottin) 
levels of all three furocoumarins and Duncan contains  the highest amount of DHB 
(2.587 ± 0.432 µg/ml) and bergamottin (1.004 ± 0.068 µg/ml), where as the highest levels 
of paradisin A was observed in Star Ruby. The highest levels of DHB (2.266 µg/ml) and 
bergamottin (2.411 µg/ml) were found in flame grown in California. The changes in the 
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levels of these furocoumarins during the season in Rio Red and March White grapefruit 
cultivars were evaluated. 
  The grapefruit juice along with isolated compounds such as bergamottin, 6’ 7’- 
dihydroxybergamottin, paradisin-A, bergaptol and geranylcoumarin were tested for their 
inhibitory effects on human CYP3A4, CYP2C9 and CYP2D6. Grapefruit and Pummelo 
juices were found to be potent inhibitors of cytochrome CYP3A4 and CYP2C9 
isoenzymes at 5% concentration while CYP2D6 was less affected.  Among the five 
furocoumarins tested, the inhibitory potency was in the order of paradisin 
A>dihydroxybergamottin>bergamottin>bergaptol>geranylcoumarin at 0.1 µM to 0.1 mM 
concentrations.  The IC50 value was lowest for paradisin A for CYP3A4 with 0.11 µM 
followed by DHB for CYP2C9 with 1.58 µM. Studies involving the grapefruit juice and 
furocoumarins on bacterial auto-inducer (AI) signaling found that, furocoumarins are 
potent inhibitors of both AI-1 and AI-2 activities at 0.01% concentration and grapefruit 
juices inhibited >99% of AI-1 and AI-2 activities at 5% concentration. Grapefruit juice 
and furocoumarins also affected biofilm formation in Escherichia coli O157:H7, 
Salmonella Typhimurium and Pseudomonas aeruginosa. In another study, involving 
synthesized furocoumarin monomers and dimer on anti-proliferative activities on normal 
and cancer cell lines, furocoumarins found to be non-toxic to normal cells. However, 
bergamottin showed a significant anti-proliferative activity in both HT-29 and MCF-7 
adenocarcinoma cell lines. 
Inhibition of cytochrome P450 enzymes by grapefruit juices and its 
furocoumarins offers some clinical advantages in improving bioavailability of poorly 
absorbed drugs and reduce the dose requirements and ultimately reducing the cost and 
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harnessing the health benefits of consuming grapefruit juice. In addition grapefruit juice 
bioactive components may act as potent inhibitor of cytochrome P450 enzymes which are 
involved in activation pro-carcinogen to carcinogen. This represents a unique mechanism 
in the anti-carcinogenesis strategy, part of which includes reducing the generation of 
reactive oxygen species. When grapefruit juice increases bioavailability of drugs by 1.5 
to 15 fold, is it feasible to explore the possibilities of using grapefruit juice as a “super-
pill” supplement?,  especially in the context of costly and comprehensively used drugs, 
such as anti-retroviral drugs.  Based on the extent of bioavailability obtained by 
single/double strength juice originating from white or red grapefruit cultivar, one can 
consider revising the dose of drugs. Considering the HIV epidemics and prices of anti-
retroviral drugs, grapefruit juice induced drug interaction offers challenge and 
opportunity to explore supplementing the drug dose with grapefruit juice or natural 
furocoumarins. Alternatively, one can isolate or synthesize the furocoumarins and use 
them as a supplement to reduce the drug doses required for effectiveness.  
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APPENDIX I 
ABBREVIATIONS USED 
 
µg: micro gram 
µl: micro liter 
AI signal: Auto Inducer signal  
CYP2C9: Cytochrome P450 2C9 
CYP2D6: Cytochrome P450 2D6 
CYP3A4: Cytochrome P450 3A4 
DEM: Delbecco’s Modifies Eagle’s Medium 
DHB: dihydroxybergamottin 
DMSO: Dimethyl sulfoxide 
DQFCOSY: Double Quantum Filter Correlated Spectra 
E-beam: electronic beam 
HPLC: High-performance liquid chromatography 
HSQC: Hetero Single Quantum Correlated Spectra 
mg: milli gram 
MS: Mass spectrometry 
NMR: nuclear magnetic resonance  
P-gp: P-glycoprotein 
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APPENDIX II 
DEFINITION OF TERMS 
 
Analytical HPLC: is a form of column chromatography used to separate components of 
interest from a mixture of compounds for analytical purposes 
 
Preparative HPLC: is a form of column chromatography used for separation and isolation 
of components from the mixture. 
 
1H NMR: is the application of nuclear magnetic resonance in NMR spectroscopy with 
respect to hydrogen. 1H NMR is characterized by chemical shifts in the range of 
+12 to -4 PPM and spin coupling between protons. The integration spectrum 
gives the proton properties in the molecule  
 
13C NMR: application of NMR with respect to carbon. This helps in identifying the 
carbon atom in an organic molecule. This is important tool in structure 
elucidation. 
 
Cytochrome P450 enzymes: are heme containing proteins with absorption maxima at 450 
nm. Cytochtome P450 enzymes are major xenobiotics metabolism enzymes in 
human and play a major role in drug metabolism and interactions. 
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COS7:  Normal cell line of African green monkey mainly used for virus replication 
studies. 
 
NIH-3T3: Norma cell lines of Swiss NIH mouse embryo used mainly for DNA 
transfection studies. 
 
MCF-7: Human breast adenocarcinoma cell line 
 
HT-29: cell line of human colon adenocarcinoma origin 
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